vancomycin has been researched along with Blood Poisoning in 409 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 99 (24.21) | 18.7374 |
1990's | 59 (14.43) | 18.2507 |
2000's | 57 (13.94) | 29.6817 |
2010's | 132 (32.27) | 24.3611 |
2020's | 62 (15.16) | 2.80 |
Authors | Studies |
---|---|
Hawser, S; Islam, K; Schneider, P | 1 |
Betriu, C; Culebras, E; Gómez, M; López-Fabal, F; Morales, G; Picazo, JJ; Rodríguez-Avial, I | 1 |
Clark, RB; Dunwoody, N; Fyfe, C; Grossman, TH; Hunt, DK; O'Brien, WJ; Plamondon, L; Rönn, M; Sun, C; Sutcliffe, JA; Xiao, XY; Zhang, WY; Zhou, J | 1 |
Gordeev, MF; Yuan, ZY | 1 |
Aspinall, SL; Buehrle, DJ; Clancy, CJ; Smith, KJ; Vu, M | 1 |
Cutrell, JB; Sanders, JM | 1 |
Chang, HY; Chang, JH; Chang, L; Chi, H; Chiu, NC; Hsu, CH; Huang, CY; Huang, DT; Huang, FY; Jim, WT; Kung, YH; Yan, PR | 1 |
Aljutayli, A; El-Haffaf, I; Marsot, A; Nekka, F | 1 |
Bjørnholt, JV; Rønnestad, A; Solevåg, AL; Stensvold, HJ; Størdal, EH | 1 |
Mause, E; Selim, M; Velagapudi, M | 1 |
Alonso-Diaz, C; Baraldi, E; Clements, MN; Donà, D; Dotta, A; Heath, PT; Hill, LF; Ilmoja, ML; Jacqz-Aigrain, E; Lutsar, I; Mahaveer, A; Metsvaht, T; Mitsiakos, G; Papaevangelou, V; Rawcliffe, L; Roilides, E; Sarafidis, K; Sharland, M; Turner, MA; Walker, AS | 1 |
Al-Jebawi, Y; Karalic, K; Mhanna, MJ; Shekhawat, P | 1 |
Abu-Sa'da, O; Afzal, U; Dawoud, TH; Khan, N; Rahmani, A; Varghese, N | 1 |
Housman, EL; Housman, ST; Lorenzo, MP; Opitz, BJ | 1 |
Cavallo, R; Corcione, S; Curtoni, A; De Benedetto, I; De Rosa, FG; Lupia, T; Mornese Pinna, S; Roberto, G; Scabini, S; Scaglione, L; Shbaklo, N | 1 |
Dewar, S; Kelly, J; Tysall, L | 1 |
Lizza, BD; Micek, ST; Raush, N | 1 |
Coronado Munoz, AJ; Lam, WM; Modem, VM; Scully, PT | 1 |
Golding, GR; Hota, SS; Kleinman, DR; McCracken, M; Mitchell, R; Smith, SW | 1 |
Duanmu, N; Fu, L; Huang, X; Wang, N | 1 |
Bace, E; Bris, R; Kacirova, I; Kanova, M; Klementa, V; Martinek, A; Petejova, N; Pribylova, L; Sigutova, R; Stejskal, D; Svagera, Z; Zadrazil, J | 1 |
Conroy, S; Magers, J; Prusakov, P; Sánchez, PJ; Speaks, S | 1 |
Evins, C; Lancaster, H; Schnee, AE | 1 |
Hayashi, T; Katayama, M; Komori, K; Mori, N; Sugiura, T; Yamaguchi, T | 1 |
Ahn, JY; Kim, HR; Kim, YC; La, YJ; Oh, DH | 1 |
Ito, Y; Kanda, N; Kano, Y; Kobuchi, S; Okumi, T; Sakaeda, T; Tachi, H | 1 |
Augusto, MF; Cavalcante, FS; Chamon, RC; da Silva Fernandes, DC; de Oliveira, TLR; Dos Santos, KRN; Ferreira, ALP; Nouér, SA | 1 |
Avachat, C; Birnbaum, AK; Healy, DP; Kagan, RJ; Sherwin, CM; Sullivan, K; Tran, NK; Wead, S | 1 |
Burnett, YJ; George, IA; Hamad, T; Hamad, Y; Nickel, KB; Olsen, MA | 1 |
Abu Taha, A; AbuTaha, SA; Al-Kharraz, T; Belkebir, S; Zyoud, SH | 1 |
Han, J; Nie, C; Pei, J; Ren, Z; Wang, C; Wang, J; Xu, F; Yang, H; Yang, J; Yang, S; Zhang, Q; Zheng, X | 1 |
Chai, MG; Cotta, MO; Farkas, A; Roberts, JA | 1 |
Ayada, G; Ben-Zvi, H; Henig, O; Nachshon, T; Nesher, L; Paul, M; Raanani, P; Shargian, L; Yahav, D | 1 |
Jia, L; Jiang, Y; Li, X; Peng, Z; Wang, Y | 1 |
Abdel Jalil, M; Abu Hammour, K; Al-Iede, M; Alsous, M; Khaled, F; Qaryouti, F | 1 |
de Cal, M; De Rosa, S; Fallico, L; Fanton, G; Lorenzin, A; Rassu, M; Risino, B; Ronco, C; Zanella, M; Zanetti, F | 1 |
Abbott, IJ; Cairns, KA; Dooley, MJ; Peel, TN; Peleg, AY; Udy, AA | 1 |
Burnham, CD; Dantas, G; DeVeaux, A; Escobedo, M; Hall-Moore, C; Ndao, IM; Radmacher, P; Schwartz, DJ; Shalon, N; Sullivan, JE; Tarr, PI; Wallace, MA; Wardenburg, K; Warner, BB | 1 |
Cho, SY; Chung, DR; Ha, YE; Huh, HJ; Huh, K; Kang, CI; Ko, JH; Lee, NY; Peck, KR; Song, JH | 1 |
Gong, X; Hong, W; Li, J; Li, N; Shen, Y; Zhang, H | 1 |
Butin, M; Callies, A; Crémet, L; Flamant, C; Gély, L; Gregoire, M; Guillouzouic, A; Launay, E; Martin-Perceval, L; Prot-Labarthe, S; Ruellan, AL; Verdier, MC | 1 |
Echizen, H; Goto, K; Takahashi, M; Tsuda, Y; Watanabe, F | 1 |
Brühwasser, C; Dettenkofer, M; Eichel, VM; Götting, T; Grundmann, H; Güldenhöven, H; Last, K; Liese, J; Martin, M; Mutters, NT; Papan, C; Sadaghiani, C; von Baum, H; Wendt, C; Werner, G | 1 |
Hu, Q; Kang, Z; Li, Z; Zhang, L; Zhang, Y | 1 |
Bai, J; Duan, M; Ji, X; Liu, J; Wen, A | 1 |
Barrios, BE; Floyd, AN; Gaddipati, S; John, V; Joyce, EL; Kaye, ME; Kulkarni, DH; McDonald, KG; Newberry, RD; Pauta, JT; Rusconi, B; Schill, EM; Udayan, S | 1 |
Heidt, J; Papaloukas, N; Timmerman, CP | 1 |
Caniff, K; Dukarevich, Y; Elfessi, Z; Liu, E; Marquez, K; Shabbir, Z | 1 |
Bogoslowski, A; Deng, J; Deppermann, C; Hickey, MJ; Hossain, M; Jorch, SK; Kubes, P; Omri, A; Peiseler, M; Surewaard, BG; van der Wal, F | 1 |
Avram, S; Dragic, S; Jovanovic, M; Kovacevic, P; Kovacevic, T; Miljkovic, B; Momcicevic, D; Vucicevic, K | 1 |
Currie, A; Ek, CJ; Lai, JCY; Levy, O; Mallard, C; Mottahedin, A; Strunk, T; Svedin, P; Wang, X | 1 |
Chen, JY; Huang, HN; Pan, CY; Su, BC; Wu, HY | 1 |
Buetti, N; Marschall, J; Piezzi, V | 1 |
Cobian, J; Hall, B; Miller, J; Wilson, K | 1 |
Baba, T; Enami, J; Hiramatsu, K; Ohsawa, H | 1 |
Becker, BJ; Denu, RA; Kleinschmidt, P; Patel, D; Shiffler, T | 1 |
Ouyang, Y; Xu, YB; Zhao, D | 1 |
Almuwallad, OK; Barnawi, AI; Kassarah, KA; Kordy, FN | 1 |
Basu, SK; Bhattarai, S; Blake, C; Bost, JE; Casto, AM; Chang, J; Chase, H; Galiote, J; Greenberg, I; Hahn, A; Hamdy, RF; Hammer, BM; Korzuch, KP; Nzegwu, N; Ortiz, N; Payne, AS; Sadler, ED; Shah, RK; Slomkowski, J; Soghier, L; Stone, B | 1 |
Kociolek, LK; Patel, S; Reuter, C; Scardina, T; Stach, L; Sun, S; Vogt, M | 1 |
Alsallaq, R; Dao, TH; Ferrolino, J; Hayden, RT; Margolis, EB; Parsons, JB; Rafiqullah, IM; Robinson, DA; Rosch, JW; Rubnitz, JE; Wolf, J | 1 |
Asada, M; Chuma, M; Goda, M; Ishizawa, K; Kondo, M; Okada, N; Oto, J; Shibata, A; Takechi, K; Yanagawa, H; Zamami, Y | 1 |
Hrabovsky, V; Kacirova, I; Kanova, M; Klementa, V; Martinek, A; Petejova, N; Sigutova, R; Stejskal, D; Svagera, Z; Zadrazil, J | 1 |
Arjun, R; Jalaludeen, S; Mohan, V; Niyas, VKM; Prabhakaran, A; Ratheesh, RS; Sasidharan, A; Uduman, S | 1 |
Oliver, JE; Shorman, MA; Veve, MP; Wright, LR; Yeager, SD | 1 |
Jiao, Z; Li, H; Li, Z; Sun, H; Wang, C; Xu, F | 1 |
Burdette, SD; Elliott, BP; Madden, JA; Markert, RJ; Pleiman, CM; Speelmon, EC; Tang, MM | 1 |
Adam, D; Burau, D; Derendorf, H; Genzel-Boroviczény, O; Kloft, C; Muench, HG; Schroepf, S; Zeitlinger, M | 1 |
Chen, CC; Huang, CC; Lin, YC; Wang, ST | 1 |
Pannu, AK; Saroch, A; Sharma, N | 1 |
Kaenkumchorn, T; Kesavan, A | 1 |
Butler-Wu, SM; Cummings, L; Hahn, A; Jain, R; Rakita, RM; Salipante, SJ; Sengupta, D; Waalkes, A; Weaver, T; Werth, BJ | 1 |
Ariyoshi, N; Fujishiro, T; Hattori, N; Ishii, I; Ishikawa, M; Matsubara, H; Miyauchi, H; Oami, T; Oda, S; Suzuki, T; Takatsuka, H; Yamazaki, S | 1 |
DeSimone, JA; Nambiar, PH; Tokarczyk, M | 1 |
Deresinski, S; Watkins, RR | 1 |
Macri, A; Maxfield, L; Schlick, T; Thatcher, J | 1 |
Lorenzo, MP; MacConaghy, L; Meola, G; Miller, CD; Pratt, B; Probst, LA; Seabury, RW; Steele, J | 1 |
Chu, F; Dunlay, R; Fedullo, P; Le, C; Villar, J; Wardi, G | 1 |
Bhargava, V; Fonseca, R; George, L; Malloy, M | 1 |
Hewagama, S; Krishnaswamy, S; Lipman, J; Roberts, JA; Stewart, PC; Tsai, D; Wallis, SC | 1 |
Ben-Shimol, S; Berlak, N; Chertok, IA; Goldinger, G; Greenberg, D; Melamed, R; Shany, E | 1 |
Janković, SM | 1 |
Danelli, T; Duarte, FC; Grion, CMC; Kerbauy, G; Morguette, AEB; Perugini, MRE; Tavares, ER; Yamada-Ogatta, SF; Yamauchi, LM | 1 |
Cho, SK; Costa, AB; Dangayach, NS; Kaji, DA; Kim, JS; Oermann, EK; Zech, JR | 1 |
Alemkere, G; Engidawork, E; Tenna, A | 1 |
Ahmed, A; Gardezi, A; Khadim, MT; Sabir, N; Satti, L; Zaman, G | 1 |
Chuma, M; Imai, T; Iwabuchi, S; Kikuchi, N; Kinoshita, K; Kuwana, T; Makishima, M; Nakayama, T; Sakaue, T; Sawada, N; Sekimoto, M; Suzuki, S; Tochikura, N; Yoshida, Y | 1 |
Alowami, S; Chin-Yee, B; El-Helou, P; Gangji, A; Lee, S; Lo, CK; Ribic, C; Wang, MK | 1 |
Butin, M; Laurent, F | 1 |
Černá, O; Pokorná, P; Šíma, M; Slanař, O | 1 |
Allegaert, K; Černá, O; Pokorná, P; Šíma, M; Slanař, O; Tibboel, D | 1 |
Germano, A; Heffernan, AJ; Kimura, E; Roberts, JA; Sime, FB | 1 |
Rodvold, KA | 1 |
Chen, XJ; Gao, W; Hua, CZ; Jing, CM; Lin, AW; Lu, HP; Lyu, Q; Wang, CQ; Xu, HM; Xu, ZW; Yang, LH; Yu, H | 1 |
Chuma, M; Makishima, M | 1 |
Deenen, MJ; Ter Heine, R | 1 |
Buhlinger, KM; Faircloth, CB; Fuller, KA; Wallace, JR | 1 |
Chiletti, R; Cranswick, N; Curtis, N; Gwee, A; Sosnin, N | 1 |
Herwald, H | 1 |
Covajes, C; Jacobs, F; Lipman, J; Roberts, JA; Taccone, FS; Udy, AA; Vincent, JL | 1 |
Cabeza-Osorio, L; Hermosa, C; Sanz-Rojas, P; Serrano-Heranz, R | 1 |
Ahn, SH; Fowler, VG; Sharma-Kuinkel, BK; Yan, Q; Zhang, Y | 1 |
Abdelhadii, A; Beumier, M; Cianferoni, S; De Backer, D; Devigili, A; Jacobs, F; Ocampos-Martinez, E; Penaccini, L; Scolletta, S; Taccone, FS; Vincent, JL | 1 |
Eisenbach, C; Mischnik, A; Sandig, C; Steinebrunner, N; Stremmel, W; Zimmermann, S | 1 |
Beumier, M; Cotton, F; Hites, M; Jacobs, F; Kabtouri, H; Lipman, J; Roberts, JA; Taccone, FS; Vincent, JL; Wolff, F | 1 |
Healy, D; Kagan, R; Neely, A; Sherwin, CM; Spigarelli, MG; Stockmann, C; Wead, S | 1 |
Dinda, V; Gunturu, R; Hakeem, A; Kariuki, S; Kimang'a, A; Raja, A | 1 |
Matsue, K; Nishida, Y; Sugihara, H; Takeuchi, M; Ugai, T; Yamakura, M | 1 |
Casner, M; Hill, M; Hoesli, SJ; Slaughter, JC; Weitkamp, JH | 1 |
Emmert, MY; Nguyen, TD; Scherman, J; Zilla, P | 1 |
Sharma, A; Sharma, V | 1 |
Denetclaw, TH; Dowling, TC; Steinke, D | 1 |
Dacombe, PJ; Evans, J; Gosling, OB; Heal, J | 1 |
Ha, CW; Park, YB; Park, YG; Shaikh, AA | 1 |
Brodowska-Kania, D; Dzierżanowska, M; Gomółka, M; Józefczak-Bergier, E; Niemczyk, S; Rymarz, A | 1 |
van den Anker, JN | 1 |
Bayer, O; Breuel, H; Busch, M; Claus, RA; Otto, GP; Riedemann, NC; Schlattmann, P; Sossdorf, M | 1 |
Aleksandrova, IV; Borisova, LA; Chernen'kaia, TV; Kosolapov, DA; Nikitina, OV; Reĭ, SI | 1 |
Locke, RG; Mackley, A; Novitsky, A; Paul, DA; Saiman, L; Tuttle, D | 1 |
Chang, CH; Chang, SC; Chen, SC; Chen, SY; Chen, WJ; Chiang, WC; Chie, WC; Hsueh, PR; Huang, EP; Lai, MS; Lin, CF | 1 |
Dhanireddy, R; Dolapo, O; Talati, AJ | 1 |
Ceriani Cernadas, JM; Fernández Jonusas, S; Garsd, A; Mariani, G; Márquez, M | 1 |
Cho, MH; Ha, YE; Kim, DH; Kong, KH; Song, YS; Yoon, SY | 1 |
Adam, R; Michels, G; Müller, C; Nosseir, NS; Pfister, R; Wiesen, MH | 1 |
Atmaca, S; Dal, T; Dayan, S; Deveci, Ö; Özcan, N; Tekin, A; Tekin, R | 1 |
Handler, SM; Kane-Gill, SL; Kellum, JA; Murugan, R; Sileanu, FE; Trietley, GS | 1 |
Atıcı, S; Bakır, M; Cerit, K; Kadayifci, EK; Karaaslan, A; Sarmış, A; Söyletir, G; Soysal, A | 1 |
Barlam, TF; Miller, NS; Valencia-Rey, P; Weinberg, J | 1 |
Baumgarten, G; Bode, C; Boehm, O; Diedrich, B; Hoeft, A; Jahnert, S; Meyer, R; Muenster, S; Steinhagen, F; Weisheit, C | 1 |
Dahners, L; Del Gaizo, DJ; Ledbetter, E; Liu, A; Medda, S; van der Horst, AS; Weinhold, P | 1 |
Bhandary, S; Rao, K; Rao, LG; Shetty, PR | 1 |
Cofré, F; Delpiano, L; Izquierdo, G; Labraña, Y; Reyes, A; Sandoval, A | 1 |
Cook, GK; Fischer, M; Rex, DK; Robb, BW; Rogers, NA; Sipe, BW; Vuppalanchi, R | 1 |
Berselli, A; Bertacchini, S; Capuzzo, M; Fogagnolo, A; Marangoni, E; Ragazzi, R; Spadaro, S; Volta, CA | 1 |
Duszynska, W; Hurkacz, M; Kübler, A; Taccone, FS; Wiela-Hojenska, A | 1 |
Butin, M; Claris, O; Kearns, A; Laurent, F; Martins-Simões, P; Picaud, JC; Rasigade, JP; Vandenesch, F | 1 |
Jacqz-Aigrain, E; Leroux, S; Sharland, M; van den Anker, JN; Zhao, W | 1 |
Bishara, J; Bronstein, E; Goldberg, E; Leibovici, L; Paul, M; Yahav, D | 1 |
Demirel, B; Demirel, U; Gursoy, T; İmamoglu, E; Karatekin, G; Ovali, F; Topçuoglu, S | 1 |
Bhongsatiern, J; Desai, PB; Korgenski, KE; Roberts, JK; Sherwin, CM; Spigarelli, MG; Stockmann, C; Yu, T | 1 |
Coronado-Álvarez, NM; Parra-Ruiz, J | 1 |
El-Ibiary, S; Gorlitsky, B | 1 |
Arnold, R; Comer, D; Davis, JJ; Levine, BJ; Muenzer, J; Papas, MA; Rosini, JM | 1 |
Melhus, Å; Starlander, G; Tellgren-Roth, C | 1 |
Cahill, MP; Herrera, A; Merriman, JA; Salgado-Pabón, W; Schlievert, PM; Stach, CS; Vu, BG | 1 |
Beumier, M; Cotton, F; Creteur, J; Cristallini, S; Hites, M; Jacobs, F; Kabtouri, H; Lipman, J; Roberts, JA; Taccone, FS; Vincent, JL | 1 |
Abdulsalam, A; Kamaldeen, B; Roaa, Z; Shahid, G; Tariq, AF | 1 |
Dimitriou, G; Gkentzi, D; Kolyva, S; Marangos, M; Spiliopoulou, I | 1 |
Belzer, C; Cranendonk, DR; de Vos, AF; de Vos, WM; Lankelma, JM; van der Poll, T; Wiersinga, WJ | 1 |
Choi, HJ; Choi, YJ; Jang, HC; Kang, CI; Kim, ES; Kim, HY; Kim, JY; Kim, MJ; Kim, SI; Kim, SW; Kim, YS; Lee, CS; Lee, MS; Lee, SS; Park, DW; Peck, KR; Ryu, SY; Sohn, JW; Yang, KS; Yoon, YK | 1 |
Dezsenyi, B; Fried, K; Gergely Szabo, B; Kadar, B; Kamotsay, K; Kunovszki, P; Nikolova, R; Prinz, G; Szidonia Lenart, K | 1 |
Allegaert, K; Atkinson, A; Bajcetic, M; Samardzic, J; Smits, A; Soldatovic, I; Spriet, I; Van Den Anker, JN | 1 |
Caya, C; Chong, J; Lévesque, S; Quach, C | 1 |
Chuma, M; Imai, T; Kaburaki, M; Kikuchi, N; Kinoshita, K; Makishima, M; Sakaue, T; Tochikura, N; Yoshida, Y | 1 |
Beardsley, J; Johnson, J; Liu, P; Luther, V; Ohl, C; Williamson, J | 1 |
Eissing, T; Ellger, B; Hempel, G; Horn, D; Lanckohr, C; Meyer, M; Radke, C | 1 |
Domínguez-Herrera, J; Labrador-Herrera, G; López-Rojas, R; Pachón, J; Smani, Y | 1 |
Bhargava, V; Fonseca, R; Malloy, M | 1 |
Babu, P; Bakthavatchalam, YD; David, T; Devanga Ragupathi, NK; Munuswamy, E; Veeraraghavan, B | 1 |
Flores, M; Murillo, J; Stumpf, PG | 1 |
Al-Hwiesh, AK | 1 |
Collins, CD; Hyzy, RC; Kaul, DR | 1 |
Figueiredo Costa, S | 1 |
Kruse, BT; Vadeboncoeur, TF | 1 |
Bulzico, DA; Cabizuca, CA; Conceição, FL; de Almeida, MH; Vaisman, M | 1 |
Goldman, DL; Janow, G; Lambert, B; Rosen, O; Scheiner, M; Soghier, L | 1 |
Hohlweg-Majert, B; Kesting, MR; Koulocheris, P; Metzger, MC | 1 |
Asner, S; Buclin, T; Calandra, T; Erard, V; Lamoth, F; Marchetti, O | 1 |
Bilal, M; Cleveland, KO; Gelfand, MS | 1 |
Chahales, P; Collin, M; Daniel, A; Euler, C; Fischetti, VA; Gorelick, KJ | 1 |
Anastasiou, A; Athanasiou-Metaxa, M; Badouraki, M; Farmaki, E; Gombakis, N; Karkos, C; Tasiopoulou, D; Vargiami, EG; Zafeiriou, DI | 1 |
Charles, BG; Heng, SC; Lee, TC; Lim, CT; Lo, YL; van Hasselt, JG | 1 |
Al-Obeid, S; Cherkaoui, A; François, P; Haddad, Q; Schrenzel, J | 1 |
Bansal, D; Gautam, V; Marwaha, N; Marwaha, RK; Oberoi, S; Sharma, RR | 1 |
Jacobs, F; Taccone, FS | 1 |
Fleer, A; Hemels, MA; Krediet, TG; van den Hoogen, A; Verboon-Maciolek, MA | 1 |
Begg, EJ; Borrie, TL; Darlow, BA; Lynn, AM; Robertshawe, BJ; Vella-Brincat, JW | 1 |
Hilpert, JW; Kees, MG; Vögeler, S | 1 |
Bahr, MH; Behrman, SW; Dickson, PV; Zarzaur, BL | 1 |
Pagani, L | 1 |
Misawa, Y; Morita, H; Oki, S; Saito, T | 1 |
Beloborodov, VB; Gruver, KP; Kuz'menko, TN | 1 |
Amann, K; Bröcker, EB; Müller, PA; Trautmann, A | 1 |
Docobo-Pérez, F; Domínguez-Herrera, J; Lepe, JA; López-Rojas, R; Pachón, J; Pichardo, C; Ruiz-Valderas, R | 1 |
Aleksandrova, IV; Borisova, LA; Chernen'kaia, TV; Kosolapov, DA; Vorob'eva, TIu | 1 |
Lipman, J; Roberts, JA; Udy, AA | 1 |
Friedrich, AW; Gounaris, A; Kimouli, M; Koumaki, V; Papadopoulou, M; Petropoulou, D; Tsakris, A; Vrioni, G | 1 |
Lodise, TP; Paterson, DL; van Hal, SJ | 1 |
Abdelhadii, A; Cianferoni, S; Cotton, F; de Backer, D; Devigili, A; Jacobs, F; Ocampos-Martinez, E; Penaccini, L; Scolletta, S; Taccone, FS; Vincent, JL | 1 |
Ben Saïd, M; Bes, M; Claris, O; Etienne, J; Grando, J; Laurent, F; Picaud, JC; Rasigade, JP; Raulin, O; Tellini, C; Tigaud, S | 1 |
Baptista, JP; Martins, PJ; Pimentel, JM; Sousa, E | 1 |
Fleer, A; Hemels, MA; Krediet, TG; Paauw, A | 1 |
Brown, JE; Christensen, KJ; Fominaya, C; Lamp, KC; McConnell, SA | 1 |
Eyer, F; Hapfelmeier, A; Huber, W; Nowack, MC; Phillip, V; Saugel, B; Schmid, RM; Schultheiss, C; Thies, P; Umgelter, A | 1 |
Brozmanova, H; Duricova, J; Grundmann, M; Kacirova, I; Martinek, A; Petejova, N; Urbanek, K; Zahalkova, J | 1 |
Allegaert, K; Pacifici, GM | 1 |
Duricová, J; Grundmann, M; Kacířová, I; Martínek, A; Petejová, N; Plášek, J; Valkovský, I; Zahálková, J | 1 |
Linasmita, P | 1 |
Matejovic, M; Radej, J | 1 |
Alraies, MC; Alraiyes, AH; Amro, O; Khader, S; Shaheen, K | 1 |
Brozmannova, H; Duricova, J; Grundmann, M; Kacirova, I; Martinek, A; Petejova, N; Plasek, J; Urbanek, K; Zahalkova, J | 1 |
Jacqz-Aigrain, E; Sharland, M; van den Anker, JN; Zhao, W | 1 |
Brilene, T; Jürna-Ellam, M; Kalinina, J; Kiis, M; Kõljalg, S; Lõivukene, K; Lutsar, I; Metsvaht, T; Sepp, E; Soeorg, H; Stšepetova, J | 1 |
Abdelhadii, A; Beumier, M; Covajes, C; de Backer, D; Jacobs, F; Ocampos-Martinez, E; Penaccini, L; Scolletta, S; Taccone, FS; Vincent, JL | 1 |
Campbell, RA; Franks, Z; Holloway, JT; Kraemer, BF; Marvin, JE; Rondina, MT; Vieira de Abreu, A; Weyrich, AS; Zimmerman, GA | 1 |
Kinsella, J; MacGregor, G; Smith, AJ; Thakker, B | 1 |
Chua, A; Jimenez, VE; Tortora, G; Younus, F | 1 |
Bae, KG; Jung, IS; Kim, CH; Lim, DS; Song, JY; Yun, YS | 1 |
Jarvis, WR; Levine, G; Rubin, LG; Saiman, L; Sánchez, PJ; Siegel, J | 1 |
Brown, N; Kelsall, AW; McClure, RJ; Tan, WH | 1 |
Bove, EL; Chenoweth, CE; Kulik, TJ; Maher, KO; Mosca, RS; VanDerElzen, K | 1 |
DAVIS, A; MANN, AJ; RAMSAY, AM | 1 |
CARSON, NA; WALLACE, IR | 1 |
DORMER, AE | 1 |
CAREY, RJ | 1 |
DIAMOND, EF | 1 |
ARANA, JA; BAZAN, A; KEFALIDES, NA; ROSENTHAL, SM; VELARDE, N | 1 |
TOMPSETT, R | 1 |
BAUER, AW; KIRBY, WM; PERRY, DM | 1 |
Al Hammadi, AY; El Desoky, ES; Sheikh, AA | 1 |
Burke, D; Catton, JA; Dobbins, BM; Kite, P; McMahon, MJ; Wood, JM | 1 |
Crews, JH; Isler, CM; Magann, EF; Martin, JN; Rinehart, BK; Terrone, DA | 1 |
Benjamin, DK; Bloom, B; Clark, R; Powers, R; Sanchez, P; White, R | 1 |
Cambra, F; Fortuny, C; Noguera, A; Palomeque, A; Pons, M | 1 |
Palasuntheram, C; Perera, S | 1 |
Baker, CJ; Campbell, JR; Edwards, MS; Healy, CM; Palazzi, DL | 1 |
Alp, E; Canoz, O; Doganay, M; Gozukucuk, S; Kirmaci, B | 1 |
Balaban, N; Cirioni, O; D'Amato, G; Del Prete, MS; Dell'Acqua, G; Ghiselli, R; Giacometti, A; Mocchegiani, F; Orlando, F; Rocchi, M; Saba, V; Scalise, G; Silvestri, C | 1 |
Patel, NC; Vanchiere, JA | 1 |
Balik, M; Kolar, M; Pachl, J; Sedivy, J; Smejkalova, V; Waldauf, P | 1 |
Akiyama, O; Hagiwara, K; Matsuno, H; Sato, T | 1 |
Imai, T; Isobe, K; Itoh, S; Masuya, K; Okada, H | 1 |
Maki, DG; Safdar, N | 1 |
Borschel, DM; Chenoweth, CE; Collins, CD; Hyde, KV; Kaufman, SR; Raghunathan, TE; Saint, S; VanDerElzen, KA | 1 |
Lipman, J; Roberts, JA | 1 |
Agus, N; Anil, M; Helvaci, M; Ozkalay, N; Sirti, S | 1 |
Bodonaik, NC; Moonah, S | 1 |
Ferrieri, P; Harker-Murray, P; Lee, AB; Schleiss, MR; Tolar, J | 1 |
Bochnia, M; Fraczek, M; Jankowska-Konsur, A; Jaworska, M; Kubacka, M; Mazur, M; Preś, K; Rostkowska-Nadolska, B; Steinmetz-Beck, A | 1 |
Feferbaum, R; Kobayashi, CE; Machado, JK; Sanches, C; Santos, SR | 1 |
Al-Nammari, SS; Lam, KS; Lucas, JD | 1 |
Altunay, L; Arslan, D; Erdogan, S; Kose, M; Ozturk, MK; Yikilmaz, A | 1 |
Boronat, A; Buroni, M; Fagiolino, P; Maldonado, C; Vázquez, M | 1 |
Badr, M; Barbotte, E; Cambonie, G; Devine, C; Meyer, P; Milesi, C; Picaud, JC; Pidoux, O; Plan, O | 1 |
Chuah, SK; Dhawan, VK; Maier, MK; Nayyar, M; Thadepalli, H | 1 |
Goodhart, GL | 1 |
Grosfeld, JL; Kleiman, M; Scherer, LR; Weber, TR; West, KW | 1 |
Edelson, PJ; Noel, GJ | 1 |
Bodey, GP; Bolivar, R; Fainstein, V; Hay, M; Jadeja, L; Keating, M; McCredie, K | 1 |
Ikigai, H; Nagao, T; Ozawa, A; Sawamura, S | 1 |
Connolly, MG; Craven, DE; Hsieh, CR; Kollisch, NR; McCabe, WR | 1 |
Coppens, L; Hanson, B; Klastersky, J | 1 |
Coppens, L; Klastersky, J; Meunier-Carpentier, F; van der Auwera, P | 1 |
Francioli, P; Masur, H; Murray, HW; Ruddy, M | 1 |
Bodey, GP; Bolivar, R; Jadeja, L; Silcox, VA; Wallace, RJ | 1 |
Armstrong, D; Brown, AE; Friedman, LE; Miller, DR | 1 |
Ericsson, C | 1 |
Borchardt, KA; Botch, VH; Schecter, G | 1 |
Baumgart, S; Campos, JM; Hall, SE; Polin, RA | 1 |
Chapin, M; Dudnick, DV; Gale, RP; Ho, WG; Martin, WJ; Winston, DJ | 1 |
Linnemann, CC; Myers, JP | 1 |
Coppens, L | 1 |
Hurse, A; McDonald, M; Sim, KN | 1 |
King, K | 1 |
Chevrel, B | 1 |
Foldes, M; Munro, R; Packham, DR; Shanker, S; Sorrell, TC | 1 |
Brown, WJ; Cushing, RD; Jui, J; Levine, DP | 1 |
Newman, KA; Schimpff, SC; Wade, JC; Wiernik, PH | 1 |
Carvounis, CP; Murphy, RG; Tortora, GT; Zeitlin, J | 1 |
Kaplan, RL; Landau, W; Smith, DJ; Trenholme, GM | 1 |
Casanova, P; Gallais, H; Kohler, JL; Raoult, D | 1 |
Righter, J; Zwerver, J | 1 |
Levine, M; Ling, EW; McDougal, A | 1 |
Bohnen, JM; Burnett, RJ; Dellinger, EP; Haverstock, DC; Reinhart, HH; Rotstein, OD; Solomkin, JS; Vogel, SB | 1 |
Barker, GJ; Call, SK; Gamis, AS | 1 |
Ane, M; Claeyssens, S; Fedacou, F; Guitard, J; Izard, P; Juricic, M; Krimou, A; Lemozy, J; Prere, MF; Rubie, H | 1 |
Cooper, I; Noskin, GA; Peterson, LR | 1 |
Herzum, M; Hoffmann, J; Maisch, B | 1 |
Kikuchi, K; Kobayashi, M; Okada, S; Oomori, Y; Shimizu, K; Tomonaga, O; Totsuka, K; Yoshida, K | 1 |
Campbell, PB; Flexman, JP; Palladino, S | 1 |
Belghit, M; Brunet, F; Dhainaut, JF; Karmochkine, M; Lanore, JJ; Mira, JP; Monsallier, JF | 1 |
Chow, AW; Jewesson, PJ; Kureishi, A; Phillips, GL | 1 |
Spencer, RC | 1 |
Altirriba Valls, O; Andreu Duat, MD; Demestre Guasch, X; Farré Riba, R; Ginovart Galiana, G; Mangues Bafalluy, A; Raspall Torrent, F | 1 |
Maezawa, H; Nakazawa, Y; Saitoh, A; Sakai, O; Sakamoto, M; Saruta, K; Shiba, K; Shindo, N; Yoshida, M; Yoshikawa, K | 1 |
Amaker, RD; Bhatia, J; DiPiro, JT | 1 |
Gatermann, S; Gortner, L; Iven, H; Jensen, R; Möller, JC; Nelskamp, I | 1 |
Belliveau, P; Kleinjan, J; Lai, KK | 1 |
Dawson, JD; Edmond, MB; Ober, JF; Weinbaum, DL; Wenzel, RP | 1 |
Thornton, J; Todd, NJ; Webster, NR | 1 |
Casewell, MW; Rolando, N; Wade, JJ; Williams, R | 1 |
Goudemand, J; Kiefel, V; Mannessier, L; Mizon, P; Mueller-Eckhardt, C | 1 |
Burstein, AH; Forrest, A; Gal, P | 1 |
Asano, K; Fuse, A; Hashizume, T; Nagano, R; Naito, T; Nakagawa, S; Shibata, K | 1 |
Gatermann, S; Gortner, L; Iven, H; Jensen, R; Kohl, M; Möller, JC; Nelskamp, I; Reiss, I | 1 |
Degener, JE; Kosterink, JG; Mulder, JG | 1 |
Cooke, RW; Damjanovic, V; Hart, CA; Nycyk, JA; Okuonghuae, H; Shah, V | 1 |
Anandan, JV; Touchette, MA | 1 |
de Lumley, L; Denis, F; Grélaud, C; Martin, C; Ploy, MC | 1 |
Fleer, A; Krediet, TG | 1 |
al-Tawfiq, JA; Cushing, HE; Robb, JL; Sorensen, SJ; Wise, SL | 1 |
Fleer, A; Gerards, LJ; Jones, ME; Krediet, TG | 1 |
Bergman, R; Friedman-Birnbaum, R; Sprecher, E | 1 |
Abbondi, M; Borgonovi, M; Candiani, G; Parenti, F; Romanò, G | 1 |
Claeys, G; De Baere, T; Peleman, R; Steyaert, S; Vaneechoutte, M; Verschraegen, G | 1 |
Isaacs, D | 1 |
Cole, E; Glover, ML; Wolfsdorf, J | 1 |
Barrington, KJ; Craft, AP; Finer, NN | 1 |
de Hoog, M; Mouton, JW; Schoemaker, RC; van den Anker, JN | 1 |
Aihara, Y; Fukamachi, K; Hori, T; Imamura, T; Kasuya, H; Kawashima, A; Kikuchi, K; Ochiai, T; Shiseki, M; Tozuka, K; Yamaguchi, K | 1 |
Azimi, PH; Brenner, RA; Clark, P; Clemens, J; Gill, V; Lin, FY; Philips, JB; Pratt, E; Regan, J; Rhoads, GG; Troendle, J; Weisman, LE | 1 |
Burnie, J; D'arcy, S; Gottardello, P; Hodgetts, S; Jiman-Fatami, A; Matthews, R | 1 |
Bettington, H; Goldsmith, DJ; Pattison, JM; Sheerin, N; Tahir, H; Thomas, G | 1 |
Buescher, ES; Karlowicz, MG; Surka, AE | 1 |
Banevicius, MA; Li, J; Nicolau, DP; Nightingale, CH; Onyeji, CO | 1 |
Brinquin, L; Koeck, JL; Petitjeans, F; Rousseau, JM; Villevieille, T; Vincenti-Rouquette, I | 1 |
Donta, I; Giamarellou, H; Iliopoulos, D; Karayiannakos, P; Katsarolis, I; Kyroudi-Voulgari, A; Pefanis, A; Siaperas, P | 1 |
Jin, D; Wu, H; Wu, Z; Xu, J | 1 |
Atkins, JL; Dziewulski, P; Hidvegi, N; Teare, L | 1 |
Jog, SM; Patole, SK | 1 |
Carratalà, J | 1 |
Blazevic, D; Laverdiere, M; Sabath, LD; Wheeler, N; Wilkinson, BJ | 1 |
Crossley, K; Faville, RJ; Kaplan, EL; Quie, PG; Sabath, LD; Zaske, DE | 1 |
Hook, EW; Sipes, JN; Thompson, RL | 1 |
Lykkegaard Nielsen, M; Scheibel, JH; Wamberg, T | 2 |
Counts, GW; Meyers, JD; Stamm, WE; Thomas, ED; Tompkins, LS; Wagner, KF | 1 |
Braine, HG; Pearson, TA; Rathbun, HK | 1 |
Glotzbecker, C; Watanakunakorn, C | 1 |
Cobbs, CG; Holley, HP; Reymann, MT | 1 |
Barcenas, CG; Cohen, R; Elms, J; Fuller, TJ; White, MG | 1 |
Carlet, J; Carlotti, A; Daniel, F; Fichelle, JM; Janier, M; Paul, C; Tamion, F | 1 |
Godula-Stuglik, U; Mikusz, G; Pawłowski, M | 1 |
Zhu, F | 1 |
Arakawa, M; kawashima, T; Tsukasa, H; Wada, K | 1 |
Corcoran, GD; Gibbons, N; Mulvihill, TE | 1 |
Gilbert, DN; Kimbrough, RC; Wood, CA | 1 |
Epstein, JB; Williams, PM | 1 |
Avent, K; Cobbs, G; Dill, R; Graves, A; Lyon, D; Smith, K | 1 |
Jackson, A; Kamthan, AG; Oppenheim, BA; Ranson, MR; Scarffe, JH | 1 |
Cheng, AF; Donnan, S; French, GL; Ling, JM; Mo, P | 1 |
Chomarat, M; Espinouse, D | 1 |
Boyer, G; Darbas, H; Donadio, D; Monnet, P; Ramounau-Pigot, A | 1 |
Ema, H; Hoshino, M; Imagawa, S; Itoh, M; Komatsu, N; Kurata, H; Suzuki, T; Tsunoda, J; Tsunoda, S; Yoshida, M | 1 |
Barbadora, K; Green, M; Wadowsky, RM | 1 |
Brunet, F; Dreyfus, F; Giraud, T; Monsallier, JF; Schremmer, B; Vaxelaire, JF; Vedel, G | 1 |
Aloia, MR; Burke, JP; Classen, DC; Elliott, JA; Evershed, S; Ford, CD; Wilfahrt, JK | 1 |
Bayer, AS; Nelson, RJ; Slama, TG | 1 |
Aravena, M; Golledge, CL; Joske, D; Stingemore, N | 1 |
Henrickson, KJ; Powell, K; Roghmann, K; Schwartz, C | 1 |
Barrett, M; Koontz, FP; Pfaller, MA; Veach, LA; Wenzel, RP | 1 |
Watanakunakorn, C | 1 |
Epstein, MF; Freeman, J; Goldmann, DA; Platt, R; Sidebottom, DG; Smith, NE | 1 |
Hift, R; Meissner, PN; Sohnius, U | 1 |
Appel, J; Facklam, RR; Lozano, P; Mastro, TD; Spika, JS | 1 |
Bingen, E; Cezard, JP; Lambert-Zechovsky, N; Mariani-Kurkdjian, P; Navarro, J | 1 |
Amsterdam, D; Beam, TR; Gorzynski, EA; Rotstein, C | 1 |
Baker, CJ; Kaplan, SL; Mason, EO; Parisi, JT; Patrick, CC | 1 |
Mason, AD; McManus, AT; McManus, WF; Pruitt, BA | 1 |
Arlet, G; Leblanc, T; Leverger, G; Schaison, G; Siguret, V | 1 |
Kahane, Y; Michowiz, SD; Pomeranz, S; Samuel-Cahn, E; Shapiro, M; Shuval, R; Simchen, E; Wald, U; Wax, Y; Zagzag, D | 1 |
Cheng, AF; French, GL | 1 |
Ehni, WF; Reller, LB | 1 |
Harris, M; Shanson, DC; Shehata, A; Tadayon, M | 1 |
Clumeck, N; De Wit, S; Goosens, H; Hermans, P; Van Laethem, Y | 1 |
Bartlett, J; Champlin, RE; Deresinski, S; Finley, RS; Ho, WG; Joshi, JH; Karp, J; Levitt, L; Talbot, G; Winston, DJ | 1 |
Allouche, G; Couturier, C; Demeocq, F; Malpuech, G; Sirot, J; Storme, B | 1 |
Attal, M; Huguet, F; Lemozy, J; Massip, P; Pris, J; Régnier, C; Robert, A; Rubie, H | 1 |
Benhamou, E; Blaise, D; Gaspard, MH; Hartman, O; Kalifa, C; Maraninchi, D; Patte, C; Stoppa, AM; Vassal, G; Viens, P | 1 |
Kunihiro, M; Nakamura, I; Unoki, T | 1 |
Isenberg, HD; Rubin, LG; Shapiro, J; Vellozzi, EM | 1 |
Keane, CT; Keogh, JA; Moore, DP; Munnelly, P; O'Brien, AA | 1 |
Bergman, MM; Ebert, TH; Glew, RH | 1 |
Isenberg, HD; Rubin, LG; Shapiro, J; Vellozzi, E | 1 |
Gress, J; Hathorn, JW; Marshall, D; Pizzo, PA; Rubin, M; Steinberg, SM | 1 |
Baltch, AL; Hammer, MC; Michelsen, P; Pressman, HL; Schaffer, C; Shayegani, M; Smith, RP | 1 |
Facklam, RR; Gilligan, PH; Kaplan, AH | 1 |
Catlin, EA; Hardy, S; Ignacio Santos, J; Ruoff, KL | 1 |
Chambers, HF; Miller, RT; Newman, MD | 1 |
Braun, SD; Cohan, RH; Davis, WK; Miner, DG | 1 |
Bothof, T; de Mulder, P; de Pauw, B; de Witte, T; Janssen, J; Verhagen, CS; Williams, K | 1 |
Bishburg, E; Eng, RH; Scadutto, P; Smith, SM | 1 |
Reimer, LG | 1 |
Barriere, SL; Fekety, R; Kaatz, GW; Schaberg, DR | 1 |
Gray, JL; Medoff, G; Smith, MD; Woodward, RS | 1 |
Barg, NL; Fekety, R; Supena, RB | 1 |
Frei, R; Gratwohl, A; Osterwalder, B; Reber, H; Speck, B | 1 |
Finger, H; Wirsing von König, CH | 1 |
Cafferkey, MT; Hone, R; Keane, CT | 1 |
Fiere, D; Guyotat, D; Plonton, C | 1 |
Klastersky, J; Legrand, JC; Meunier-Carpentier, F; Thys, JP; Van der Auwera, P | 1 |
Amren, DP; Bisno, AL; Dajani, AS; Durack, DT; Gerber, MA; Kaplan, EL; Millard, HD; Sanders, WE; Schwartz, RH; Shulman, ST | 1 |
Darrell, JH | 1 |
Riley, HD | 1 |
Carbon, C; Vachon, F | 1 |
Arteaga, A; González, MA | 1 |
Bottone, EJ; McCarthy, LR | 1 |
Bartlett, RC; Howell, RM | 1 |
Bottone, EJ; Keusch, GT; Ravreby, WD | 1 |
von Oldershausen, HF | 1 |
Schmitt-Slomska, J | 1 |
Chan, HC; Chan, TL; Feng, PH | 1 |
Hohenegger, M; Ivansich, H | 1 |
Ross, S | 1 |
Paterson, PY; Westenfelder, GO | 1 |
Bengtsson, E; Svanbom, M; Tunevall, G | 1 |
Castronuovo, JJ; Friedman, EA; Goodwin, NJ | 1 |
Amstutz, P; Bazin, C; Binet, JP; Cachera, JP; Coulaud, JP; Emile, J; Vachon, F; Witchitz, S | 1 |
37 review(s) available for vancomycin and Blood Poisoning
Article | Year |
---|---|
New potent antibacterial oxazolidinone (MRX-I) with an improved class safety profile.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bone Marrow Cells; Clinical Trials, Phase I as Topic; Drug Design; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Monoamine Oxidase Inhibitors; Oxazolidinones; Pyridones; Sepsis | 2014 |
An Update on Population Pharmacokinetic Analyses of Vancomycin, Part II: In Pediatric Patients.
Topics: Adolescent; Anti-Bacterial Agents; Area Under Curve; Child; Humans; Infant; Metabolic Clearance Rate; Models, Biological; Retrospective Studies; Sepsis; Vancomycin | 2022 |
Cefazolin-induced hemolytic anemia: a case report and systematic review of literature.
Topics: Aged, 80 and over; Anemia, Hemolytic; Anti-Bacterial Agents; Cefazolin; Female; Humans; Pneumonia, Bacterial; Sepsis; Vancomycin | 2021 |
Therapeutics for Vancomycin-Resistant Enterococcal Bloodstream Infections.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Gram-Positive Bacterial Infections; Humans; Linezolid; Sepsis; Vancomycin; Vancomycin-Resistant Enterococci | 2023 |
Epidemiology and outcomes of vancomycin-resistant enterococcus infections: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Sepsis; Vancomycin; Vancomycin-Resistant Enterococci | 2023 |
Acute Kidney Injury in Septic Patients Treated by Selected Nephrotoxic Antibiotic Agents-Pathophysiology and Biomarkers-A Review.
Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Biomarkers; Gentamicins; Humans; Kidney; MicroRNAs; Sepsis; Vancomycin | 2020 |
Crusted scabies in a renal transplant recipient treated with daily ivermectin: A case report and literature review.
Topics: Administration, Oral; Aged; Animals; Diagnosis, Differential; Exanthema; Humans; Immunosuppression Therapy; Ivermectin; Kidney Transplantation; Male; Recurrence; Sarcoptes scabiei; Scabies; Sepsis; Skin; Vancomycin | 2019 |
Staphylococcus capitis and NRCS-A clone: the story of an unrecognized pathogen in neonatal intensive care units.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Sepsis; Staphylococcal Infections; Staphylococcus capitis; Vancomycin; Virulence | 2019 |
How to optimize the evaluation and use of antibiotics in neonates.
Topics: Aminoglycosides; Evaluation Studies as Topic; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Sepsis; Vancomycin | 2014 |
[Therapeutic Drug Monitoring of antiinfectives in intensive care medicine].
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Biological Availability; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Fluoroquinolones; Guideline Adherence; Humans; Intensive Care Units; Linezolid; Metabolic Clearance Rate; Microbial Sensitivity Tests; Oxazolidinones; Sepsis; Shock, Septic; Teicoplanin; Vancomycin | 2014 |
[Reinstating cloxacilin for empiric antibiotic in late-onset sepsis].
Topics: Anti-Bacterial Agents; Cloxacillin; Coagulase; Drug Repositioning; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Practice Patterns, Physicians'; Sepsis; Staphylococcal Infections; Vancomycin | 2015 |
How to use vancomycin optimally in neonates: remaining questions.
Topics: Anti-Bacterial Agents; Computer Simulation; Dose-Response Relationship, Drug; Drug Monitoring; Gram-Positive Bacterial Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Sepsis; Vancomycin | 2015 |
Treatment Options for Persistent Coagulase Negative Staphylococcal Bacteremia in Neonates.
Topics: Anti-Infective Agents; Daptomycin; Dose-Response Relationship, Drug; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Linezolid; Retrospective Studies; Rifampin; Sepsis; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2016 |
Heteroresistant Vancomycin Intermediate Coagulase Negative Staphylococcus in the NICU: A Systematic Review.
Topics: Coagulase; Humans; Intensive Care Units, Neonatal; Quebec; Sepsis; Staphylococcus; Vancomycin | 2016 |
New developments in antimicrobial use in sepsis.
Topics: Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Drug Resistance, Multiple, Bacterial; Humans; Methicillin Resistance; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2008 |
Impact of antimicrobial resistance on the treatment and outcome of patients with sepsis.
Topics: Anti-Infective Agents; beta-Lactamases; Cohort Studies; Drug Resistance, Microbial; Enterobacteriaceae; Enterococcus; Humans; Hypotension; Microchip Analytical Procedures; Pseudomonas aeruginosa; Sepsis; Staphylococcus aureus; Treatment Outcome; Vancomycin; Virulence | 2008 |
Leuconostoc septicemia in a preterm neonate on vancomycin therapy: case report and literature review.
Topics: Anti-Bacterial Agents; Diagnosis, Differential; Female; Gram-Positive Bacterial Infections; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Leuconostoc; Risk Factors; Sepsis; Streptococcal Infections; Vancomycin; Vancomycin Resistance; Viridans Streptococci | 2009 |
The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Sepsis; Staphylococcal Infections; Treatment Failure; Vancomycin; Vancomycin Resistance | 2012 |
Clinical pharmacokinetics of vancomycin in the neonate: a review.
Topics: Age Factors; Anti-Bacterial Agents; Drug Monitoring; Humans; Infant, Newborn; Infant, Premature, Diseases; Kidney; Sepsis; Vancomycin | 2012 |
[An effect of continuous and intermittent renal replacement therapy on antibiotic treatment in critically ill patients with sepsis - a practice-based perspective of vancomycin and gentamycin therapies].
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Critical Illness; Gentamicins; Humans; Renal Dialysis; Sepsis; Shock, Septic; Vancomycin | 2012 |
Use of antibacterial agents in the neonate: 50 years of experience with vancomycin administration.
Topics: Anti-Bacterial Agents; Drug Monitoring; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Microbial Sensitivity Tests; Sepsis; Vancomycin | 2013 |
CHEMOTHERAPY OF BACTERIAL ENDOCARDITIS.
Topics: Anti-Bacterial Agents; Diagnosis; Endocarditis, Bacterial; Enterococcus faecalis; Humans; Penicillin G; Penicillin G Procaine; Penicillins; Procaine; Sepsis; Staphylococcal Infections; Streptococcal Infections; Vancomycin | 1963 |
DIAGNOSIS AND TREATMENT OF BACTERIAL ENDOCARDITIS.
Topics: Bacteriological Techniques; Diagnosis; Embolism; Endocarditis, Bacterial; Erythromycin; Fever; Heart Defects, Congenital; Heart Valves; Humans; Lung Diseases; Penicillin Resistance; Penicillins; Pneumococcal Infections; Postoperative Complications; Prognosis; Sepsis; Staphylococcal Infections; Streptococcal Infections; Streptomycin; Tetracycline; Vancomycin | 1964 |
Prevention and treatment of nosocomial sepsis in the NICU.
Topics: Anti-Bacterial Agents; Blood-Borne Pathogens; Candidiasis; Cross Infection; Humans; Hygiene; Immunoglobulins, Intravenous; Infant, Newborn; Infection Control; Intensive Care Units, Neonatal; Process Assessment, Health Care; Sepsis; Vancomycin | 2004 |
Use of vancomycin-containing lock or flush solutions for prevention of bloodstream infection associated with central venous access devices: a meta-analysis of prospective, randomized trials.
Topics: Adult; Anti-Bacterial Agents; Catheterization, Central Venous; Child; Humans; Sepsis; Treatment Outcome; Vancomycin | 2006 |
Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; beta-Lactams; Ciprofloxacin; Critical Care; Drug Administration Schedule; Drug Monitoring; Humans; Sepsis; Vancomycin | 2006 |
Methicillin-resistant Staphylococcus aureus bacteraemia.
Topics: Catheterization; Cross Infection; Humans; Methicillin; Middle Aged; Neoplasms; Penicillin Resistance; Pneumonia; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1981 |
Teicoplanin versus vancomycin in the empirical treatment of febrile neutropenic patients.
Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow Transplantation; Catheterization, Central Venous; Catheters, Indwelling; Combined Modality Therapy; Double-Blind Method; Drug Therapy, Combination; Female; Fever; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Incidence; Kidney Diseases; Leukemia; Male; Middle Aged; Multicenter Studies as Topic; Neutropenia; Penicillins; Prevalence; Prospective Studies; Sepsis; Superinfection; Teicoplanin; Tobramycin; Treatment Outcome; Vancomycin | 1993 |
Teicoplanin in gram-positive infection: microbiological aspects.
Topics: Catheterization, Central Venous; Catheters, Indwelling; Equipment Contamination; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Sepsis; Staphylococcal Infections; Staphylococcus epidermidis; Teicoplanin; Vancomycin | 1993 |
Vancomycin clearance with high-flux dialysis membranes.
Topics: Acrylic Resins; Anti-Bacterial Agents; Biocompatible Materials; Humans; Kidney Failure, Chronic; Membranes, Artificial; Polymers; Polymethyl Methacrylate; Renal Dialysis; Sepsis; Sulfones; Vancomycin | 1998 |
Vancomycin for prophylaxis against sepsis in preterm neonates.
Topics: Anti-Bacterial Agents; Cross Infection; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Sepsis; Staphylococcal Infections; Vancomycin | 2000 |
The antibiotic-lock technique for therapy of 'highly needed' infected catheters.
Topics: Anti-Bacterial Agents; Bacterial Infections; Catheterization; Humans; Parenteral Nutrition; Sepsis; Vancomycin | 2002 |
Prophylaxis of infective endocarditis: a reevaluation.
Topics: Animals; Anti-Bacterial Agents; Cardiac Surgical Procedures; Cardiovascular Diseases; Endocarditis, Bacterial; Endoscopy; Female; Gingival Diseases; Heart Diseases; Humans; Infusions, Parenteral; Male; Penicillins; Rabbits; Renal Dialysis; Rheumatic Heart Disease; Sepsis; Streptomycin; Substance-Related Disorders; Tonsillectomy; Tooth Extraction; Urogenital System; Vancomycin | 1977 |
[Erythroderma induced by teicoplanin].
Topics: Adult; Dermatitis, Exfoliative; Humans; Male; Sepsis; Staphylococcal Infections; Teicoplanin; Vancomycin | 1992 |
Current concepts in prevention of prosthetic valve endocarditis.
Topics: Animals; Cephalosporins; Endocarditis, Bacterial; Heart Valve Prosthesis; Humans; Premedication; Sepsis; Vancomycin | 1990 |
Vancomycin and novobiocin.
Topics: Deafness; Drug Eruptions; Drug Hypersensitivity; Drug Resistance, Microbial; Endocarditis, Bacterial; Enterocolitis, Pseudomembranous; Fever; Humans; Novobiocin; Sepsis; Staphylococcal Infections; Vancomycin | 1970 |
[Actual problems in clinical chemotherapy].
Topics: Anti-Bacterial Agents; Antitubercular Agents; Cephalosporins; Endocarditis, Bacterial; Enteritis; Gentamicins; Humans; Infections; Lincomycin; Meningitis; Penicillins; Rifampin; Sepsis; Staphylococcal Infections; Streptococcal Infections; Sulfonamides; Urinary Tract Infections; Vancomycin | 1967 |
34 trial(s) available for vancomycin and Blood Poisoning
Article | Year |
---|---|
Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trial.
Topics: Anti-Bacterial Agents; Equivalence Trials as Topic; Europe; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Intensive Care Units, Neonatal; Sepsis; Spain; Time Factors; Treatment Outcome; United Kingdom; Vancomycin | 2022 |
Antibiotic use practice and predictors of hospital outcome among patients with systemic bacterial infection: Identifying targets for antibiotic and health care resource stewardship.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Female; Health Resources; Humans; Length of Stay; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Sepsis; Vancomycin | 2019 |
Clinical outcome of neonates with nosocomial suspected sepsis treated with cefazolin or vancomycin: a non-inferiority, randomized, controlled trial.
Topics: Anti-Bacterial Agents; Cefazolin; Cross Infection; Humans; Infant, Newborn; Prospective Studies; Sepsis; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2014 |
External validity of a randomised controlled trial on the treatment of severe infections caused by MRSA.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cognition; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Odds Ratio; Patient Selection; Sepsis; Severity of Illness Index; Staphylococcal Infections; Treatment Failure; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2015 |
Antibiotic-induced gut microbiota disruption during human endotoxemia: a randomised controlled study.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Drug Monitoring; Endotoxemia; Escherichia coli; Gastrointestinal Microbiome; Healthy Volunteers; Humans; Immunity, Innate; Klebsiella pneumoniae; Male; Metronidazole; Sepsis; Streptococcus pneumoniae; Treatment Outcome; Vancomycin | 2017 |
Tunneled catheter-antibiotic lock therapy for prevention of dialysis catheter-related infections: a single center experience.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Catheterization, Central Venous; Child; Creatinine; Gentamicins; Hematocrit; Humans; Infant; Middle Aged; Prevalence; Renal Dialysis; Saudi Arabia; Sepsis; Vancomycin | 2008 |
Can bioimpedance determine the volume of distribution of antibiotics in sepsis?
Topics: Anti-Bacterial Agents; Critical Care; Drug Monitoring; Humans; Metabolic Clearance Rate; Middle Aged; Netilmicin; Sepsis; Vancomycin | 2005 |
Continuous-infusion vancomycin therapy for preterm neonates with suspected or documented Gram-positive infections: a new dosage schedule.
Topics: Anti-Bacterial Agents; Creatinine; Drug Administration Schedule; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infusions, Intravenous; Male; Prospective Studies; Sepsis; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2008 |
Therapy of staphylococcal infections with cefamandole or vancomycin alone or with a combination of cefamandole and tobramycin.
Topics: Anti-Bacterial Agents; Cefamandole; Cephalosporins; Drug Therapy, Combination; Humans; Methicillin; Penicillin Resistance; Sepsis; Staphylococcal Infections; Staphylococcus; Tobramycin; Vancomycin | 1983 |
Definition of the role of enterococcus in intraabdominal infection: analysis of a prospective randomized trial.
Topics: Abscess; Adult; Anti-Infective Agents; Bacteremia; Ciprofloxacin; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Logistic Models; Male; Metronidazole; Middle Aged; Peritonitis; Prospective Studies; Sepsis; Treatment Failure; Vancomycin | 1995 |
Oral care with vancomycin paste for reduction in incidence of alpha-hemolytic streptococcal sepsis.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Cohort Studies; Humans; Incidence; Infant; Leukemia, Myeloid, Acute; Mouth Diseases; Neoplasms; Neutropenia; Ointments; Oral Hygiene; Retrospective Studies; Sepsis; Streptococcal Infections; Streptococcus; Vancomycin | 1995 |
Recovery from staphylococcal septicaemia in neutropenic patients without removal of the previously inserted central venous catheter.
Topics: Adult; Catheterization; Catheterization, Central Venous; Humans; Middle Aged; Neutropenia; Sepsis; Staphylococcal Infections; Vancomycin | 1993 |
Teicoplanin versus vancomycin in the empirical treatment of febrile neutropenic patients.
Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow Transplantation; Catheterization, Central Venous; Catheters, Indwelling; Combined Modality Therapy; Double-Blind Method; Drug Therapy, Combination; Female; Fever; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Incidence; Kidney Diseases; Leukemia; Male; Middle Aged; Multicenter Studies as Topic; Neutropenia; Penicillins; Prevalence; Prospective Studies; Sepsis; Superinfection; Teicoplanin; Tobramycin; Treatment Outcome; Vancomycin | 1993 |
Pharmacokinetics of vancomycin in critically ill infants undergoing extracorporeal membrane oxygenation.
Topics: Anti-Bacterial Agents; Extracorporeal Membrane Oxygenation; Female; Half-Life; Humans; Infant, Newborn; Infusions, Intravenous; Male; Models, Biological; Practice Guidelines as Topic; Respiratory Insufficiency; Sepsis; Vancomycin | 1996 |
Teicoplanin pharmacology in prophylaxis for coagulase-negative staphylococcal sepsis of very low birthweight infants.
Topics: Anti-Bacterial Agents; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Prospective Studies; Sepsis; Staphylococcal Infections; Teicoplanin; Vancomycin | 1996 |
Central venous line sepsis in the intensive care unit. A study comparing antibiotic coated catheters with plain catheters.
Topics: Anti-Bacterial Agents; Catheterization, Central Venous; Critical Care; Equipment Contamination; Humans; Sepsis; Staphylococcal Infections; Vancomycin | 1996 |
Comparison of vancomycin and teicoplanin for prophylaxis of sepsis with coagulase negative staphylococci (CONS) in very low birth weight (VLBW) infants.
Topics: Anti-Bacterial Agents; Coagulase; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Prospective Studies; Sepsis; Staphylococcus; Teicoplanin; Vancomycin | 1997 |
Low-dose vancomycin prophylaxis reduces coagulase-negative staphylococcal bacteraemia in very low birthweight infants.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; England; Female; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Infection Control; Intensive Care Units, Neonatal; Male; Sepsis; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1997 |
Septic complications in colo-rectal surgery after 24 hours versus 60 hours of preoperative antibiotic bowel preparation. I. Prospective, randomized, double-blind clinical study.
Topics: Adult; Aged; Anti-Bacterial Agents; Clinical Trials as Topic; Colectomy; Colon; Colostomy; Double-Blind Method; Drug Evaluation; Female; Gentamicins; Humans; Male; Middle Aged; Nystatin; Preoperative Care; Prospective Studies; Rectum; Sepsis; Surgical Wound Infection; Time Factors; Vancomycin | 1978 |
Septic complications in colo-rectal surgery after 24 hours versus 60 hours of preoperative antibiotic bowel preparation. II. Significance of bacterial concentrations in the bowel for contamination of the operation field and subsequent wound infection.
Topics: Adult; Aged; Anti-Bacterial Agents; Ascitic Fluid; Bacteria; Clinical Trials as Topic; Colectomy; Colon; Double-Blind Method; Drug Evaluation; Female; Gentamicins; Humans; Male; Middle Aged; Nystatin; Preoperative Care; Rectum; Sepsis; Skin; Surgical Wound Infection; Time Factors; Vancomycin | 1978 |
Failure of treatment with teicoplanin at 6 milligrams/kilogram/day in patients with Staphylococcus aureus intravascular infection. The Infectious Diseases Consortium of Oregon.
Topics: Adult; Aged; Aged, 80 and over; Aneurysm, Infected; Angiography; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Endocarditis, Bacterial; Female; Femoral Artery; Glycopeptides; Humans; Male; Middle Aged; Prospective Studies; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 1991 |
Double-blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients.
Topics: Adolescent; Adult; Aged; Catheterization, Central Venous; Double-Blind Method; Female; Humans; Immune Tolerance; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Premedication; Randomized Controlled Trials as Topic; Sepsis; Vancomycin | 1990 |
[Prevention of septicemia caused by gastrointestinal tract organisms in patients with granulopenia. Comparison of three gastrointestinal tract decontamination treatments].
Topics: Agranulocytosis; Colistin; Drug Therapy, Combination; Gastrointestinal Diseases; Humans; Nystatin; Sepsis; Tobramycin; Vancomycin | 1991 |
Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Cancer In
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Bacterial Infections; Ceftazidime; Child; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; Gram-Positive Bacteria; Humans; Infant; Male; Middle Aged; Neoplasms; Prospective Studies; Sepsis; Vancomycin | 1991 |
Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organisms.
Topics: Adolescent; Catheterization, Central Venous; Child; Child, Preschool; Double-Blind Method; Female; Heparin; Humans; Immunosuppressive Agents; Infant; Male; Randomized Controlled Trials as Topic; Sepsis; Vancomycin | 1990 |
Randomized clinical trial of intra-operative antimicrobial prophylaxis of infection after neurosurgical procedures.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cerebrospinal Fluid Shunts; Clinical Trials as Topic; Double-Blind Method; Female; Gentamicins; Humans; Intraoperative Period; Male; Meningitis; Neurosurgery; Pneumonia; Postoperative Complications; Random Allocation; Sepsis; Surgical Wound Infection; Urinary Tract Infections; Vancomycin | 1986 |
Comparison of intravenous teicoplanin with intramuscular amoxycillin for the prophylaxis of streptococcal bacteraemia in dental patients.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Glycopeptides; Humans; Middle Aged; Sepsis; Streptococcal Infections; Streptococcus; Teicoplanin; Tooth Extraction; Vancomycin | 1987 |
Teicoplanin compared with vancomycin in methicillin-resistant Staphylococcus aureus infections: preliminary results.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Female; Glycopeptides; Humans; Male; Methicillin; Middle Aged; Penicillin Resistance; Random Allocation; Recurrence; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 1988 |
Norfloxacin for prevention of bacterial infections in granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Bacterial Infections; Drug Combinations; Drug Therapy, Combination; Humans; Middle Aged; Mycoses; Norfloxacin; Polymyxins; Random Allocation; Sepsis; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1987 |
[Prophylaxis of Gram-positive infections after bone marrow graft. Controlled study of the 6-day administration of vancomycin. Intermediate analysis of 60 patients].
Topics: Adolescent; Bacterial Infections; Bone Marrow Transplantation; Child; Child, Preschool; Drug Administration Schedule; Gram-Positive Bacteria; Humans; Infant; Infant, Newborn; Postoperative Complications; Premedication; Sepsis; Vancomycin | 1988 |
Randomized prospective study of ceftazidime versus ceftazidime plus cephalothin in empiric treatment of febrile episodes in severely neutropenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Bacterial Infections; Bronchopneumonia; Ceftazidime; Cephalothin; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Prospective Studies; Random Allocation; Sepsis; Vancomycin | 1987 |
A randomized trial of oral vancomycin in neutropenic patients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Agranulocytosis; Antineoplastic Agents; Clinical Trials as Topic; Colistin; Gentamicins; Humans; Leukemia; Middle Aged; Neutropenia; Nystatin; Sepsis; Vancomycin | 1985 |
Double-blind, placebo-controlled study of oxacillin combined with rifampin in the treatment of staphylococcal infections.
Topics: Blood Bactericidal Activity; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Oxacillin; Random Allocation; Rifampin; Sepsis; Staphylococcal Infections; Vancomycin | 1985 |
Topical vancomycin as a deterrent to bacteremias following dental procedures.
Topics: Adult; Bacteria; Clinical Trials as Topic; Dental Prophylaxis; Dental Scaling; Humans; Ointments; Postoperative Care; Preoperative Care; Sepsis; Tooth Extraction; Vancomycin | 1973 |
339 other study(ies) available for vancomycin and Blood Poisoning
Article | Year |
---|---|
Iclaprim, a novel diaminopyrimidine with potent activity on trimethoprim sensitive and resistant bacteria.
Topics: Animals; Drug Resistance, Bacterial; Folic Acid Antagonists; Lung; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Pyrimidines; Sepsis; Staphylococcus aureus; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase; Trimethoprim Resistance; Vancomycin | 2003 |
Comparative activities of TR-700 (torezolid) against staphylococcal blood isolates collected in Spain.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; In Vitro Techniques; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Sepsis; Spain; Staphylococcal Infections; Tetrazoles; Vancomycin | 2010 |
Fluorocyclines. 1. 7-fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: a potent, broad spectrum antibacterial agent.
Topics: Animals; Anti-Bacterial Agents; Cyclophosphamide; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Gram-Negative Bacteria; Gram-Positive Bacteria; Male; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Neutropenia; Pyrrolidines; Rats; Rats, Sprague-Dawley; Ribosomes; Sepsis; Stereoisomerism; Structure-Activity Relationship; Tetracycline Resistance; Tetracyclines | 2012 |
Exploratory Cost-Effectiveness Analysis for Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections: Is Linezolid or Daptomycin Favored Over Vancomycin?
Topics: Acetamides; Anti-Bacterial Agents; Cost-Benefit Analysis; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Sepsis; Staphylococcal Infections; Vancomycin | 2021 |
"The Early Beta-Lactam Catches the Germ": Empiric Antimicrobial Sequence in Bloodstream Infections.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Humans; Lactams; Sepsis; Vancomycin | 2022 |
Reducing catheter related bloodstream infection risk of infant with a prophylactic antibiotic therapy before removing peripherally inserted central catheter: A retrospective study.
Topics: Anti-Bacterial Agents; Catheter-Related Infections; Catheterization, Central Venous; Catheters; Central Venous Catheters; Humans; Infant; Retrospective Studies; Risk Factors; Sepsis; Vancomycin | 2022 |
Sepsis treatment options identified by 10-year study of microbial isolates and antibiotic susceptibility in a level-four neonatal intensive care unit.
Topics: Anti-Bacterial Agents; Gentamicins; Humans; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Microbial Sensitivity Tests; Neonatal Sepsis; Sepsis; Vancomycin | 2022 |
The concomitant use of vancomycin and piperacillin-tazobactam is associated with acute kidney injury (AKI) in extremely low birth weight infants (ELBW).
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Case-Control Studies; Drug Therapy, Combination; Female; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis; Vancomycin | 2022 |
Assessment of initial vancomycin trough levels and risk factors of vancomycin-induced nephrotoxicity in neonates.
Topics: Adolescent; Anti-Bacterial Agents; Child; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Risk Factors; Sepsis; Vancomycin | 2022 |
Assessment of an online calculator's vancomycin dosing and exposure appropriateness in persons who inject drugs with methicillin-resistant Staphylococcus aureus bloodstream infections.
Topics: Anti-Bacterial Agents; Area Under Curve; Drug Users; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pilot Projects; Reproducibility of Results; Retrospective Studies; Sepsis; Staphylococcal Infections; Substance Abuse, Intravenous; Vancomycin | 2022 |
Clinical and microbiological characteristics of bloodstream infections caused by Enterococcus spp. within internal medicine wards: a two-year single-centre experience.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Bacteremia; Endocarditis; Enterococcus; Gram-Positive Bacterial Infections; Hospitals; Humans; Internal Medicine; Retrospective Studies; Sepsis; Vancomycin | 2022 |
Daptomycin susceptibility testing and therapeutic use in enterococcal bloodstream infection (EBSI) in a setting with high rates of vancomycin-resistant Enterococcus faecium (VREfm).
Topics: Anti-Bacterial Agents; Daptomycin; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Sepsis; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Antibiotic Optimization in the Intensive Care Unit.
Topics: Anti-Bacterial Agents; beta-Lactams; Critical Illness; Humans; Intensive Care Units; Retrospective Studies; Sepsis; Vancomycin | 2022 |
Augmented Renal Clearance of Vancomycin in Suspected Sepsis: Single-Center, Retrospective Pediatric Cohort.
Topics: Adult; Anti-Bacterial Agents; Child; Humans; Prospective Studies; Retrospective Studies; Sepsis; Vancomycin | 2022 |
Vancomycin-resistant
Topics: Canada; Cross Infection; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals; Humans; Multilocus Sequence Typing; Retrospective Studies; Sepsis; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2023 |
Early Warning and Clinical Epidemiological Characteristics of Lung Injury in the Treatment of Infectious
Topics: Algorithms; Humans; Lung; Lung Injury; Sepsis; Staphylococcus aureus; Vancomycin | 2022 |
Expression and 7-day time course of circulating microRNAs in septic patients treated with nephrotoxic antibiotic agents.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Circulating MicroRNA; Creatinine; Female; Gentamicins; Humans; Interleukin-6; Lipocalin-2; Male; MicroRNAs; Procalcitonin; Sepsis; Vancomycin | 2022 |
Safety and Efficacy of Nafcillin for Empiric Therapy of Late-Onset Sepsis in the NICU.
Topics: Anti-Bacterial Agents; Child; Humans; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Methicillin-Resistant Staphylococcus aureus; Nafcillin; Retrospective Studies; Sepsis; Staphylococcal Infections; Vancomycin | 2022 |
Successful use of dalbavancin in the treatment of gram positive blood stream infections: a case series.
Topics: Anti-Bacterial Agents; Bacteremia; Endocarditis; Humans; Retrospective Studies; Sepsis; Teicoplanin; Vancomycin | 2022 |
Invasive pectoral abscess and costal osteomyelitis with bloodstream infection caused by methicillin-resistant Staphylococcus aureus after nasal septoplasty in an immunocompetent adult patient.
Topics: Abscess; Adult; Community-Acquired Infections; Exotoxins; Humans; Leukocidins; Male; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Osteomyelitis; Ribs; Sepsis; Staphylococcal Infections; Vancomycin | 2022 |
Comparison of Clinical Outcomes for Glycopeptides and Beta-Lactams in Methicillin-Susceptible
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cefazolin; Glycopeptides; Humans; Methicillin; Nafcillin; Retrospective Studies; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 2022 |
Comparing the pharmacokinetics and organ/tissue distribution of anti-methicillin-resistant
Topics: Acetamides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Daptomycin; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Rats; Sepsis; Tissue Distribution; Vancomycin | 2022 |
Pandemic clone USA300 in a Brazilian hospital: detection of an emergent lineage among methicillin-resistant Staphylococcus aureus isolates from bloodstream infections.
Topics: Aged; Brazil; Clone Cells; Hospitals; Humans; Methicillin-Resistant Staphylococcus aureus; Pandemics; Sepsis; Staphylococcus aureus; Vancomycin | 2022 |
Exploring the Past to Inform the Future to Optimize the Pharmacokinetics of Vancomycin in Children With Severe Burn Injuries.
Topics: Adolescent; Anti-Bacterial Agents; Burns; Child; Child, Preschool; Humans; Retrospective Studies; Sepsis; Vancomycin | 2023 |
Prevalence and risk factors associated with readmission with acute kidney injury in patients receiving vancomycin outpatient parenteral antimicrobial therapy.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Anti-Infective Agents; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Outpatients; Patient Readmission; Penicillins; Prevalence; Renal Insufficiency, Chronic; Retrospective Studies; Risk Factors; Sepsis; Vancomycin | 2022 |
Patterns of microbial resistance in bloodstream infections of hemodialysis patients: a cross-sectional study from Palestine.
Topics: Anti-Bacterial Agents; Arabs; Bacteremia; beta-Lactamases; Coagulase; Cross-Sectional Studies; Drug Resistance, Bacterial; Gentamicins; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Renal Dialysis; Retrospective Studies; Sepsis; Vancomycin | 2022 |
Reduction of antibiotic use and multi-drug resistance bacteria infection in neonates after improvement of antibiotics use strategy in a level 4 neonatal intensive care unit in southern China.
Topics: Anti-Bacterial Agents; Bacterial Infections; Drug Resistance, Multiple, Bacterial; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Meropenem; Sepsis; Vancomycin | 2023 |
Accuracy of a precision dosing software program for predicting antibiotic concentrations in critically ill patients.
Topics: Anti-Bacterial Agents; Critical Illness; Drug Monitoring; Humans; Meropenem; Piperacillin; Sepsis; Software; Vancomycin | 2023 |
Outcomes of neutropenic hemato-oncological patients with viridans group streptococci (VGS) bloodstream infection based on penicillin susceptibility.
Topics: Anti-Bacterial Agents; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillins; Sepsis; Streptococcal Infections; Vancomycin; Viridans Streptococci | 2023 |
A 12-Year Retrospective Analysis of Blood Culture Isolates in the Intensive Care Unit of a Tertiary Hospital in China.
Topics: Amikacin; Anti-Bacterial Agents; Blood Culture; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Intensive Care Units; Linezolid; Meropenem; Microbial Sensitivity Tests; Retrospective Studies; Sepsis; Teicoplanin; Tertiary Care Centers; Vancomycin | 2023 |
Vancomycin audit in the paediatric population: Patterns of use and appropriateness of therapeutic drug monitoring.
Topics: Anti-Bacterial Agents; Child; Drug Monitoring; Hospitalization; Humans; Sepsis; Vancomycin | 2023 |
Extracorporeal therapy in the treatment of sepsis: In vitro assessment of the effect of an absorbent cartridge on the circulating bacterial concentration and its interaction with the antibiotic therapy.
Topics: Anti-Bacterial Agents; Bacteria; Hemoperfusion; Humans; Sepsis; Staphylococcus aureus; Vancomycin | 2023 |
Gut pathogen colonization precedes bloodstream infection in the neonatal intensive care unit.
Topics: Ampicillin; Bacteria; Bacterial Infections; Gastrointestinal Microbiome; Gentamicins; Humans; Infant; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Sepsis; Vancomycin | 2023 |
Impact of vancomycin resistance in Enterococcus faecium bloodstream infection on mortality: A retrospective analysis of nationwide surveillance data.
Topics: Anti-Bacterial Agents; Bacteremia; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Retrospective Studies; Sepsis; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2023 |
Clinical features, management, and prognosis of Bacillus cereus sepsis in premature neonates.
Topics: Bacillus cereus; Child; China; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Meropenem; Prognosis; Retrospective Studies; Sepsis; Vancomycin | 2023 |
Safety and Efficacy of Ceftaroline in Neonates With Staphylococcal Late-onset Sepsis: A Case Series Analysis.
Topics: Anti-Bacterial Agents; Bacteremia; Ceftaroline; Humans; Infant; Infant, Newborn; Neonatal Sepsis; Sepsis; Staphylococcal Infections; Vancomycin | 2023 |
Population Pharmacokinetic Analysis of Vancomycin in Patients with Solid or Hematological Malignancy in Relation to the Quick Sequential Organ Failure Assessment Scores.
Topics: Hematologic Neoplasms; Humans; Methicillin-Resistant Staphylococcus aureus; Organ Dysfunction Scores; Retrospective Studies; Sepsis; Vancomycin | 2023 |
Kocuria species: an underappreciated pathogen in pediatric patients-a single-center retrospective analysis of 10 years' experience in China.
Topics: Anti-Infective Agents; Child; Humans; Retrospective Studies; Sepsis; Tigecycline; Vancomycin | 2023 |
Therapeutic Drug Monitoring-Guided Vancomycin Therapy of a Pediatric Patient after Liver Transplantation: a Case Report.
Topics: Anti-Bacterial Agents; Child; Drug Monitoring; Female; Humans; Infant; Liver Transplantation; Living Donors; Retrospective Studies; Sepsis; Vancomycin | 2023 |
Vancomycin-induced gut microbial dysbiosis alters enteric neuron-macrophage interactions during a critical period of postnatal development.
Topics: Animals; Anti-Bacterial Agents; Dysbiosis; Gastrointestinal Microbiome; Macrophages; Mice; Neurons; Sepsis; Vancomycin | 2023 |
A rare bloodstream infection: Bacillus mycoides.
Topics: Aged; Agricultural Workers' Diseases; Anti-Bacterial Agents; Bacillus; Blood Culture; Heart Arrest; Humans; Male; Netherlands; Resuscitation; Sepsis; Treatment Outcome; Vancomycin | 2019 |
Sepsis induced bacterial peritonitis caused by Granulicatella adiacens.
Topics: Adult; Anti-Bacterial Agents; Carnobacteriaceae; Gram-Positive Bacterial Infections; Humans; Male; Peritonitis; Sepsis; Staphylococcus aureus; Vancomycin | 2019 |
Peritoneal GATA6+ macrophages function as a portal for Staphylococcus aureus dissemination.
Topics: Animals; Female; GATA6 Transcription Factor; Macrophages, Peritoneal; Male; Mice; Peritonitis; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2019 |
Population pharmacokinetic model of Vancomycin based on therapeutic drug monitoring data in critically ill septic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Critical Illness; Drug Administration Schedule; Drug Monitoring; Female; Humans; Infusions, Intravenous; Kidney Diseases; Male; Middle Aged; Models, Biological; Nonlinear Dynamics; Prospective Studies; Sepsis; Vancomycin; Young Adult | 2020 |
Vancomycin Is Protective in a Neonatal Mouse Model of
Topics: Animals; Animals, Newborn; Blood Glucose; Brain Injuries; Female; Hypoxia-Ischemia, Brain; Infant, Premature; Male; Mice; Mice, Inbred C57BL; Sepsis; Staphylococcus epidermidis; Vancomycin | 2020 |
Epinecidin-1 Protects against Methicillin Resistant
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; C-Reactive Protein; Disease Models, Animal; Dose-Response Relationship, Drug; Fish Proteins; Methicillin-Resistant Staphylococcus aureus; Sepsis; Staphylococcal Infections; Swine; Vancomycin | 2019 |
Are Vancomycin-Resistant Enterococcal Bloodstream Infections Associated With Decreased Survival?
Topics: Bacteremia; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Myelodysplastic Syndromes; Retrospective Studies; Sepsis; Vancomycin; Vancomycin-Resistant Enterococci | 2020 |
Impact of SEP-1 on broad-spectrum combination antibiotic therapy in the emergency department.
Topics: Adult; Aged; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cefepime; Centers for Medicare and Medicaid Services, U.S.; Early Diagnosis; Early Medical Intervention; Emergency Service, Hospital; Female; Guideline Adherence; Hospital Mortality; Hospitalization; Humans; Male; Medical Overuse; Meropenem; Middle Aged; Patient Care Bundles; Piperacillin, Tazobactam Drug Combination; Reimbursement Mechanisms; Retrospective Studies; Sepsis; Shock, Septic; Soft Tissue Infections; Time-to-Treatment; United States; Urinary Tract Infections; Vancomycin | 2020 |
Protective activity of anti-lipoteichoic acid monoclonal antibody in single or combination therapies in methicillin-resistant Staphylococcus aureus-induced murine sepsis models.
Topics: Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Antibodies, Monoclonal; Daptomycin; Disease Models, Animal; Drug Therapy, Combination; Humans; Linezolid; Lipopolysaccharides; Methicillin-Resistant Staphylococcus aureus; Mice; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Teichoic Acids; Vancomycin | 2020 |
MRSA Septicemia With Septic Arthritis and Prostatic, Intraretinal, Periapical, and Lung Abscesses.
Topics: Abscess; Accidental Falls; Anti-Bacterial Agents; Arthritis, Infectious; Diabetes Mellitus, Type 2; Humans; Linezolid; Lung Abscess; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Periapical Abscess; Prostatitis; Retinal Diseases; Sepsis; Staphylococcal Infections; Vancomycin | 2020 |
Curative effects of vancomycin and cefotaxime combined with gamma globulin respectively in neonatal septicemia and their influences on PCT, CRP and hs-CRP.
Topics: C-Reactive Protein; Cefotaxime; Drug Therapy, Combination; Female; gamma-Globulins; Humans; Infant, Newborn; Injections, Intravenous; Male; Procalcitonin; Sepsis; Vancomycin | 2020 |
Early neonatal sepsis and meningitis caused by Elizabethkingia meningoseptica in Saudi Arabia.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Flavobacteriaceae; Flavobacteriaceae Infections; Humans; Infant, Newborn; Meningitis, Bacterial; Rifampin; Saudi Arabia; Sepsis; Treatment Outcome; Vancomycin | 2020 |
Reducing Vancomycin Use in a Level IV NICU.
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Brazil; Critical Pathways; Enterocolitis, Necrotizing; Hospitals, Pediatric; Hospitals, Urban; Humans; Inappropriate Prescribing; Infant, Newborn; Infant, Newborn, Diseases; Intensive Care Units, Neonatal; Pharmacy Service, Hospital; Prospective Studies; Quality Improvement; Sepsis; Vancomycin | 2020 |
Documentation of Indications: Agreement Between Order Entry and Clinical Notes and Effect on Time to Antibiotic Administration.
Topics: Adolescent; Anti-Bacterial Agents; Ceftriaxone; Documentation; Humans; Sepsis; Vancomycin | 2022 |
Vancomycin Heteroresistance and Clinical Outcomes in Bloodstream Infections Caused by Coagulase-Negative Staphylococci.
Topics: Anti-Bacterial Agents; Bacteremia; Child; Coagulase; Humans; Microbial Sensitivity Tests; Retrospective Studies; Sepsis; Staphylococcal Infections; Vancomycin | 2020 |
Successful Vancomycin Dose Adjustment in a Sepsis patient with Bacterial Meningitis Using Cystatin C.
Topics: Adult; Anti-Bacterial Agents; Biomarkers; Cystatin C; Drug Monitoring; Glomerular Filtration Rate; Humans; Male; Meningitis, Bacterial; Sepsis; Vancomycin | 2020 |
Susceptibility and serotypes of Streptococcus pneumoniae isolates in invasive pneumococcal disease: a study from Kerala, South India.
Topics: Anti-Bacterial Agents; Ceftriaxone; Humans; India; Meningitis; Microbial Sensitivity Tests; Penicillins; Pneumococcal Infections; Pneumococcal Vaccines; Retrospective Studies; Sepsis; Serogroup; Serotyping; Streptococcus pneumoniae; Vancomycin | 2020 |
Comparison of linezolid step-down therapy to standard parenteral therapy in methicillin-resistant Staphylococcus aureus bloodstream infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Daptomycin; Drug Administration Routes; Female; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Retrospective Studies; Sepsis; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2021 |
Establishment of a population pharmacokinetics model of vancomycin in 94 infants with septicemia and its application in individualized therapy.
Topics: Anti-Bacterial Agents; Computer Simulation; Female; Humans; Infant; Infant, Newborn; Male; Models, Biological; Monte Carlo Method; Precision Medicine; Sepsis; Vancomycin | 2021 |
A retrospective cohort study assessing acute kidney injury and renal recovery among septic patients empirically treated with vancomycin piperacillin-tazobactam versus vancomycin cefepime.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cefepime; Drug Therapy, Combination; Female; Humans; Male; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis; Vancomycin | 2022 |
Microdialysis sampling to monitor target-site vancomycin concentrations in septic infants: a feasible way to close the knowledge gap.
Topics: Anti-Bacterial Agents; Drug Monitoring; Humans; Infant, Newborn; Intensive Care, Neonatal; Microdialysis; Sepsis; Vancomycin | 2021 |
Temporal Trends of Acute Kidney Injury and Associated Risk Exposures in Extremely Preterm Infants.
Topics: Acute Kidney Injury; Aminoglycosides; Anti-Inflammatory Agents, Non-Steroidal; Creatinine; Female; Gestational Age; Humans; Incidence; Infant, Extremely Premature; Infant, Newborn; Intensive Care, Neonatal; Male; Patient Transfer; Premature Birth; Risk Factors; Sepsis; Taiwan; Vancomycin | 2021 |
Danger Triangle of Face and Septic Cavernous Sinus Thrombosis.
Topics: Anti-Bacterial Agents; Cavernous Sinus Thrombosis; Ceftriaxone; Drug Therapy, Combination; Heparin, Low-Molecular-Weight; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Sepsis; Vancomycin | 2017 |
A Rare Complication of Campylobacter Sepsis in an Infant.
Topics: Anti-Bacterial Agents; Anticoagulants; Campylobacter Infections; Campylobacter jejuni; Ceftriaxone; Enoxaparin; Female; Fluid Therapy; Humans; Infant; Magnetic Resonance Imaging; Portal Vein; Sepsis; Tomography, X-Ray Computed; Ultrasonography; Vancomycin; Venous Thrombosis | 2018 |
Emergence of dalbavancin non-susceptible, vancomycin-intermediate Staphylococcus aureus (VISA) after treatment of MRSA central line-associated bloodstream infection with a dalbavancin- and vancomycin-containing regimen.
Topics: Adult; Anti-Bacterial Agents; Blood; Catheter-Related Infections; DNA Mutational Analysis; Drug Resistance, Multiple, Bacterial; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Sepsis; Serial Passage; Staphylococcal Infections; Teicoplanin; Urine; Vancomycin; Whole Genome Sequencing | 2018 |
An extremely high bioavailability of orally administered vancomycin in a patient with severe colitis and renal insufficiency.
Topics: Acute Kidney Injury; Administration, Oral; Anti-Bacterial Agents; Antineoplastic Agents; Biological Availability; Colonoscopy; Enterocolitis, Pseudomembranous; Humans; Intestine, Large; Male; Middle Aged; Rectal Neoplasms; Renal Replacement Therapy; Respiration, Artificial; Sepsis; Vancomycin | 2017 |
Photo Quiz: Fatal Septicemia in an Immunocompromised Patient.
Topics: Aged; Anti-Bacterial Agents; Blood Culture; Catheter-Related Infections; Enterococcus faecium; Humans; Immunocompromised Host; Male; Pennsylvania; Sepsis; Treatment Failure; Vancomycin | 2017 |
Increasing Evidence of the Nephrotoxicity of Piperacillin/Tazobactam and Vancomycin Combination Therapy-What Is the Clinician to Do?
Topics: Anti-Bacterial Agents; Combined Modality Therapy; Drug Therapy, Combination; Humans; Kidney; Kidney Diseases; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Vancomycin | 2017 |
Vancomycin-associated drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: masquerading under the guise of sepsis.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Diagnosis, Differential; Drug Hypersensitivity Syndrome; Eosinophilia; Exanthema; Humans; Male; Methylprednisolone; Middle Aged; Pseudomonas aeruginosa; Sepsis; Vancomycin | 2017 |
Impact of a Combination Antibiotic Bag on Compliance With Surviving Sepsis Campaign Goals in Emergency Department Patients With Severe Sepsis and Septic Shock.
Topics: Administration, Intravenous; Aged; Anti-Bacterial Agents; Cefepime; Drug Administration Schedule; Drug Combinations; Emergency Service, Hospital; Female; Goals; Guideline Adherence; Humans; Male; Middle Aged; Practice Guidelines as Topic; Retrospective Studies; Sepsis; Vancomycin | 2018 |
Evaluating vancomycin and piperacillin-tazobactam in ED patients with severe sepsis and septic shock.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; California; Drug Therapy, Combination; Emergency Service, Hospital; Female; Hospital Mortality; Humans; Inappropriate Prescribing; Male; Middle Aged; Multivariate Analysis; Piperacillin, Tazobactam Drug Combination; Regression Analysis; Retrospective Studies; Sepsis; Shock, Septic; Vancomycin | 2018 |
The Role of a Single Dose of Vancomycin in Reducing Clinical Sepsis in Premature Infants Prior to Removal of Peripherally Inserted Central Catheter: A Retrospective Study.
Topics: Antibiotic Prophylaxis; Catheter-Related Infections; Catheterization, Central Venous; Catheters, Indwelling; Female; Gestational Age; Humans; Incidence; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Intensive Care Units, Neonatal; Male; Retrospective Studies; Sepsis; Texas; Vancomycin | 2018 |
Optimised dosing of vancomycin in critically ill Indigenous Australian patients with severe sepsis.
Topics: Adult; Anti-Bacterial Agents; Critical Illness; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Monte Carlo Method; Population Groups; Prospective Studies; Sepsis; Vancomycin | 2018 |
Late onset sepsis: comparison between coagulase-negative staphylococci and other bacteria in the neonatal intensive care unit.
Topics: Anti-Bacterial Agents; Coagulase; Gestational Age; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; Intensive Care Units, Neonatal; Israel; Parenteral Nutrition; Retrospective Studies; Risk Factors; Sepsis; Staphylococcal Infections; Staphylococcus; Vancomycin | 2018 |
Clinical Application of Pharmacokinetics: Basis for Rational Dose Selection in a Critically Ill Patient on Renal Replacement Therapy.
Topics: Aged; Anti-Bacterial Agents; Area Under Curve; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Meropenem; Metabolic Clearance Rate; Renal Dialysis; Sepsis; Time Factors; Treatment Outcome; Vancomycin | 2019 |
Fatal sepsis caused by mecA-positive oxacillin-susceptible Staphylococcus aureus: First report in a tertiary hospital of southern Brazil.
Topics: Adult; Brazil; Fatal Outcome; Female; Humans; Methicillin-Resistant Staphylococcus aureus; Oxacillin; Sepsis; Staphylococcal Infections; Tertiary Care Centers; Vancomycin | 2019 |
An attention based deep learning model of clinical events in the intensive care unit.
Topics: Anti-Bacterial Agents; Clinical Decision-Making; Deep Learning; Diagnosis, Computer-Assisted; Humans; Intensive Care Units; Models, Biological; Myocardial Infarction; Retrospective Studies; Sepsis; Vancomycin | 2019 |
Catheter related recurrent blood stream infection caused by linezolid-resistant, methicillin resistant Staphylococcus haemolyticus; an emerging super bug.
Topics: Anti-Bacterial Agents; Baths; Catheter-Related Infections; Chlorhexidine; Cross Infection; Humans; Injections; Linezolid; Male; Methicillin Resistance; Middle Aged; Secondary Prevention; Sepsis; Staphylococcal Infections; Staphylococcus haemolyticus; Vancomycin | 2019 |
Relationship between hemoglobin levels and vancomycin clearance in patients with sepsis.
Topics: Aged; Anti-Bacterial Agents; Female; Hemoglobins; Humans; Male; Middle Aged; Retrospective Studies; Sepsis; Vancomycin | 2019 |
Nomogram based on actual body weight for estimation of vancomycin maintenance dose in infants.
Topics: Anti-Bacterial Agents; Body Weight; Drug Monitoring; Female; Humans; Infant; Male; Nomograms; Regression Analysis; Sepsis; Staphylococcus; Vancomycin | 2019 |
Actual body weight-based vancomycin dosing in neonates.
Topics: Anti-Bacterial Agents; Body Weight; Drug Monitoring; Female; Humans; Infant, Newborn; Male; Nomograms; Sepsis; Vancomycin | 2019 |
Vancomycin population pharmacokinetics for adult patients with sepsis or septic shock: are current dosing regimens sufficient?
Topics: Adult; Anti-Bacterial Agents; Creatinine; Drug Monitoring; Enterococcus faecalis; Enterococcus faecium; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Sepsis; Staphylococcus; Vancomycin | 2019 |
60 Plus Years Later and We Are Still Trying to Learn How to Dose Vancomycin.
Topics: Adult; Anti-Bacterial Agents; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Prospective Studies; Sepsis; Vancomycin | 2020 |
A multi-center clinical investigation on invasive Streptococcus pyogenes infection in China, 2010-2017.
Topics: Ceftriaxone; Child, Preschool; China; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Female; Fever; Humans; Infant; Infant, Newborn; Male; Penicillins; Pneumonia, Pneumococcal; Retrospective Studies; Sepsis; Shock, Septic; Skin Diseases, Bacterial; Soft Tissue Infections; Streptococcal Infections; Streptococcus pyogenes; Tertiary Care Centers; Vancomycin | 2019 |
Response to: Is vancomycin clearance really correlated with hemoglobin? Arguments that it's not.
Topics: Hemoglobins; Humans; Kinetics; Sepsis; Vancomycin | 2019 |
Is vancomycin clearance really correlated with hemoglobin? Arguments that it's not.
Topics: Hemoglobins; Humans; Kinetics; Sepsis; Vancomycin | 2019 |
Effect of concomitant vancomycin and piperacillin-tazobactam on frequency of acute kidney injury in pediatric patients.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Child; Creatinine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis; Time Factors; Vancomycin | 2019 |
Vancomycin is commonly under-dosed in critically ill children and neonates.
Topics: Administration, Intravenous; Adolescent; Age Factors; Anti-Bacterial Agents; Child; Child, Preschool; Critical Illness; Dose-Response Relationship, Drug; Drug Dosage Calculations; Drug Monitoring; Female; Gestational Age; Humans; Infant; Infant, Extremely Premature; Infant, Newborn; Intensive Care Units, Neonatal; Kidney; Kidney Diseases; Male; Medical Records; Retrospective Studies; Sepsis; Vancomycin | 2019 |
Anti-inflammatory, anti-coagulant, anti-biotic?
Topics: Acetamides; Animals; Anti-Bacterial Agents; Humans; Inflammation; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Sepsis; Staphylococcal Infections; Thrombosis; Vancomycin | 2013 |
Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients?
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Critical Illness; Female; Humans; Male; Middle Aged; Models, Statistical; Plasma; Renal Replacement Therapy; Sepsis; Vancomycin | 2013 |
[Acute meningitis by Streptococcus agalactiae in a immunocompetent male].
Topics: Anti-Bacterial Agents; Cardiotonic Agents; Ceftriaxone; Combined Modality Therapy; Communicable Diseases, Emerging; Drug Therapy, Combination; Humans; Immunocompetence; Male; Meningitis, Bacterial; Middle Aged; Pharyngitis; Respiration, Artificial; Sepsis; Streptococcal Infections; Streptococcus agalactiae; Vancomycin | 2013 |
Host gene expression profiling and in vivo cytokine studies to characterize the role of linezolid and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA) murine sepsis model.
Topics: Acetamides; Animals; Gene Expression Profiling; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Oxazolidinones; Sepsis; Vancomycin | 2013 |
Development of acute kidney injury during continuous infusion of vancomycin in septic patients.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Plasma; Prevalence; Sepsis; Vancomycin | 2013 |
Salmonella enterica serovar Minnesota urosepsis in a patient with Crohn's disease in the absence of recent or current gastrointestinal symptoms.
Topics: Adult; Antibodies, Monoclonal; Ceftriaxone; Crohn Disease; Humans; Infliximab; Male; Meropenem; Recurrence; Salmonella enterica; Salmonella Infections; Sepsis; Thienamycins; Urinary Catheters; Urinary Tract Infections; Urolithiasis; Vancomycin | 2013 |
A new regimen for continuous infusion of vancomycin during continuous renal replacement therapy.
Topics: Anti-Bacterial Agents; Bacterial Infections; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Plasma; Prospective Studies; Renal Replacement Therapy; Sepsis; Vancomycin | 2013 |
Amikacin population pharmacokinetics among paediatric burn patients.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Body Surface Area; Body Weight; Burns; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Male; Multivariate Analysis; Regression Analysis; Sepsis; Vancomycin | 2014 |
Pattern of pathogens and their sensitivity isolated from surgical site infections at the Aga Khan University Hospital, Nairobi, Kenya.
Topics: Adult; Ambulatory Care Facilities; Bacillus; Developing Countries; Female; Follow-Up Studies; Hospitals, University; Humans; Incidence; Kenya; Length of Stay; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Sepsis; Staphylococcus aureus; Surgical Wound Infection; Universities; Vancomycin | 2013 |
Capnocytophaga canimorsus sepsis following BMT in a patient with AML: possible association with functional asplenia.
Topics: Animals; Anti-Bacterial Agents; Bone Marrow Transplantation; Capnocytophaga; Disease Progression; Dog Diseases; Dogs; Female; Graft vs Host Disease; Gram-Negative Bacterial Infections; Humans; Leukemia, Myeloid, Acute; Meropenem; Middle Aged; Postoperative Complications; Saliva; Sepsis; Spleen; Thienamycins; Thrombocytosis; Treatment Outcome; Vancomycin | 2014 |
Incidence of catheter-related bloodstream infections in neonates following removal of peripherally inserted central venous catheters.
Topics: Anti-Bacterial Agents; Apnea; Birth Weight; Bradycardia; Catheter-Related Infections; Catheterization, Peripheral; Catheters, Indwelling; Central Venous Catheters; Device Removal; Female; Gestational Age; Humans; Incidence; Infant, Newborn; Infant, Very Low Birth Weight; Male; Prevalence; Sepsis; Time Factors; Vancomycin | 2014 |
Huge left-ventricular pseudoaneurysm compressing coronary artery 10 weeks after stabbing attack.
Topics: Adult; Aneurysm, False; Anti-Bacterial Agents; Constriction, Pathologic; Coronary Stenosis; Heart Injuries; Heart Ventricles; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Sepsis; Staphylococcal Infections; Vancomycin; Wounds, Stab | 2014 |
From the toe to the head: metastatic endophalmitis following staphylococcal purpura fulminans.
Topics: Adult; Anti-Bacterial Agents; Endophthalmitis; Humans; Male; Purpura Fulminans; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Toes; Treatment Outcome; Vancomycin | 2014 |
Performance of a divided-load intravenous vancomycin dosing strategy for critically ill patients.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Critical Illness; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Sepsis; Vancomycin | 2013 |
Stage 3 pyomyositis of the gluteus minimus; Staphylococcus aureus sepsis, autoanticoagulation, proximal femoral osteomyelitis and the role of surgical intervention.
Topics: Anti-Bacterial Agents; Buttocks; Delayed Diagnosis; Drainage; Humans; Male; Middle Aged; Muscle, Skeletal; Osteomyelitis; Pyomyositis; Rifampin; Sepsis; Staphylococcal Infections; Vancomycin | 2013 |
Two-stage approach to primary TKA in infected arthritic knees using intraoperatively molded articulating cement spacers.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Arthroplasty, Replacement, Knee; Biomechanical Phenomena; Bone Cements; Bone Diseases, Infectious; Debridement; Female; Humans; Infection Control; Knee Joint; Knee Prosthesis; Male; Middle Aged; Osteoarthritis, Knee; Prosthesis Design; Prosthesis-Related Infections; Radiography; Range of Motion, Articular; Recovery of Function; Sepsis; Streptomycin; Time Factors; Treatment Outcome; Vancomycin | 2014 |
Vancomycin dosing in patients undergoing maintenance hemodialysis.
Topics: Aged; Anti-Bacterial Agents; Catheter-Related Infections; Drug Monitoring; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Sepsis; Vancomycin | 2014 |
Renal outcome after vancomycin treatment and renal replacement therapy in patients with severe sepsis and septic shock: a retrospective study.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; APACHE; Female; Glomerular Filtration Rate; Humans; Intensive Care Units; Length of Stay; Logistic Models; Male; Middle Aged; Renal Replacement Therapy; Retrospective Studies; Sepsis; Sex Factors; Shock, Septic; Vancomycin | 2014 |
[Pattern dynamics of bacteriemia and sepsis pathogens in ICU patients of emergency service].
Topics: Acetamides; Acinetobacter; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Candida; Candidiasis; Carbapenems; Cefoperazone; Drug Resistance, Multiple, Bacterial; Enterococcus; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Klebsiella pneumoniae; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Sepsis; Sulbactam; Vancomycin | 2013 |
Prolonged early antibiotic use and bronchopulmonary dysplasia in very low birth weight infants.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteria; Bronchopulmonary Dysplasia; Case-Control Studies; Cohort Studies; Female; Gentamicins; Humans; Infant, Extremely Premature; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Intubation, Intratracheal; Male; Respiration, Artificial; Retrospective Studies; Risk Factors; Sepsis; Time Factors; Vancomycin | 2015 |
Predicting high vancomycin minimum inhibitory concentration isolate infection among patients with community-onset methicillin-resistant Staphylococcus aureus bacteraemia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Chronic Disease; Community-Acquired Infections; Decision Support Techniques; Female; Hospitalization; Humans; Kidney Failure, Chronic; Liver Diseases; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Predictive Value of Tests; Respiratory Tract Infections; Retrospective Studies; Sepsis; Staphylococcal Infections; Vancomycin; Vancomycin Resistance | 2014 |
Trends of Staphylococcus aureus bloodstream infections in a neonatal intensive care unit from 2000-2009.
Topics: Anti-Bacterial Agents; Birth Weight; Clindamycin; Enterocolitis, Necrotizing; Hospital Mortality; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Length of Stay; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Bacterial; Retrospective Studies; Sepsis; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Tennessee; Vancomycin | 2014 |
Vancomycin blocks autophagy and induces interleukin-1β release in macrophages.
Topics: Animals; Anti-Bacterial Agents; Autophagy; Cell Line; Humans; Inflammation; Interleukin-1beta; Lipopolysaccharides; Macrophages; Mice; Sepsis; Systemic Inflammatory Response Syndrome; Vancomycin | 2015 |
In vitro susceptibility to methicillin, vancomycin and linezolid of staphylococci isolated from bloodstream infections in eastern Turkey.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; Linezolid; Methicillin; Microbial Sensitivity Tests; Oxazolidinones; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Turkey; Vancomycin | 2014 |
Risk factors for acute kidney injury in older adults with critical illness: a retrospective cohort study.
Topics: Acute Kidney Injury; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Cohort Studies; Comorbidity; Critical Illness; Female; Humans; Hypertension; Intensive Care Units; Male; Middle Aged; Retrospective Studies; Risk Factors; ROC Curve; Sepsis; Vancomycin; Young Adult | 2015 |
Lactococcus lactis Catherter-Related Bloodstream Infection in an Infant: Case Report.
Topics: Animals; Anti-Bacterial Agents; Catheter-Related Infections; Down Syndrome; Gram-Positive Bacterial Infections; Hirschsprung Disease; Humans; Infant; Infant, Newborn; Lactococcus lactis; Male; Sepsis; Treatment Outcome; Turkey; Vancomycin | 2015 |
Coagulase-negative staphylococcal bloodstream infections: Does vancomycin remain appropriate empiric therapy?
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Coagulase; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Sepsis; Staphylococcal Infections; Staphylococcus; Tertiary Care Centers; Vancomycin; Young Adult | 2015 |
Linezolid, vancomycin and daptomycin modulate cytokine production, Toll-like receptors and phagocytosis in a human in vitro model of sepsis.
Topics: Acetamides; Anti-Bacterial Agents; Cell Line; Cytokines; Daptomycin; Escherichia coli; Gene Expression Profiling; Gram-Positive Bacteria; Humans; Immunologic Factors; Linezolid; Models, Theoretical; Monocytes; Oxazolidinones; Phagocytosis; Sepsis; Toll-Like Receptors; Vancomycin | 2015 |
Combined local and systemic antibiotic treatment is effective against experimental Staphylococcus aureus peri-implant biofilm infection.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Ceftriaxone; Female; Femur; Gentamicins; Prostheses and Implants; Rats; Rats, Sprague-Dawley; Rifampin; Sepsis; Staphylococcal Infections; Stem Cells; Time Factors; Tobramycin; Vancomycin | 2015 |
Orbital cellulitis with periorbital abscess secondary to methicillin-resistant Staphylococcus aureus (MRSA) sepsis in an immunocompetent neonate.
Topics: Abscess; Acute Disease; Drainage; Humans; Infant; Male; Methicillin-Resistant Staphylococcus aureus; Orbit; Orbital Cellulitis; Sepsis; Staphylococcal Infections; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2015 |
Faecal microbiota transplantation plus selected use of vancomycin for severe-complicated Clostridium difficile infection: description of a protocol with high success rate.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colectomy; Colonoscopy; Fecal Microbiota Transplantation; Female; Humans; Male; Metronidazole; Middle Aged; Retrospective Studies; Sepsis; Shock, Septic; Vancomycin | 2015 |
Evaluation of a protocol for vancomycin administration in critically patients with and without kidney dysfunction.
Topics: Aged; Anti-Bacterial Agents; Cohort Studies; Critical Illness; Drug Dosage Calculations; Female; Humans; Kidney Diseases; Male; Middle Aged; Retrospective Studies; Sepsis; Vancomycin | 2015 |
Continuous vs. intermittent vancomycin therapy for Gram-positive infections not caused by methicillin-resistant Staphylococcus aureus.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Female; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Prospective Studies; Sepsis; Vancomycin | 2016 |
Adaptation to vancomycin pressure of multiresistant Staphylococcus capitis NRCS-A involved in neonatal sepsis.
Topics: Adaptation, Biological; Anti-Bacterial Agents; Cell Wall; Humans; Infant, Newborn; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Sepsis; Serial Passage; Staphylococcal Infections; Staphylococcus; Vancomycin | 2015 |
Comparison of intermittent versus continuous vancomycin infusion for the treatment of late-onset sepsis in preterm infants.
Topics: Anti-Bacterial Agents; Female; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infusions, Intravenous; Male; Retrospective Studies; Sepsis; Treatment Outcome; Vancomycin | 2015 |
Evaluation of Vancomycin Use in Late-Onset Neonatal Sepsis Using the Area Under the Concentration-Time Curve to the Minimum Inhibitory Concentration ≥400 Target.
Topics: Anti-Bacterial Agents; Area Under Curve; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Male; Microbial Sensitivity Tests; Models, Biological; Nonlinear Dynamics; Retrospective Studies; Sepsis; Staphylococcal Infections; Tissue Distribution; Vancomycin | 2015 |
Vancomycin does not remain appropriate empiric therapy in coagulase-negative staphylococcal bacteremia.
Topics: Anti-Bacterial Agents; Female; Humans; Male; Sepsis; Staphylococcal Infections; Staphylococcus; Vancomycin | 2016 |
A Common But Not so Typical Elevated Anion Gap.
Topics: Acetone; Acidosis; Adult; Anti-Bacterial Agents; Blood Glucose; Confusion; Diabetes Complications; Fever; Fluid Therapy; Humans; Leg Injuries; Male; Methicillin-Resistant Staphylococcus aureus; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Sodium Bicarbonate; Staphylococcal Infections; Vancomycin | 2016 |
High Single-dose Vancomycin Loading Is Not Associated With Increased Nephrotoxicity in Emergency Department Sepsis Patients.
Topics: Anti-Bacterial Agents; Body Weight; Dose-Response Relationship, Drug; Emergency Service, Hospital; Humans; Incidence; Kidney Diseases; Patient Admission; Retrospective Studies; Sepsis; Vancomycin | 2016 |
Fatal acquisition of vanD gene during vancomycin treatment of septicaemia caused by Enterococcus faecium.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; Enterococcus faecium; Fatal Outcome; Female; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Peptide Synthases; Sepsis; Vancomycin; Vancomycin Resistance | 2016 |
Novel Tissue Level Effects of the Staphylococcus aureus Enterotoxin Gene Cluster Are Essential for Infective Endocarditis.
Topics: Animals; Anti-Bacterial Agents; Bacterial Toxins; Disease Models, Animal; Drug Therapy, Combination; Endocarditis, Bacterial; Enterotoxins; Female; Immunoglobulins, Intravenous; Immunologic Factors; Male; Rabbits; Sepsis; Shock, Septic; Staphylococcal Infections; Staphylococcus aureus; Superantigens; Vancomycin | 2016 |
New Regimen for Continuous Infusion of Vancomycin in Critically Ill Patients.
Topics: Aged; Anti-Bacterial Agents; Critical Illness; Female; Humans; Infusions, Intravenous; Intensive Care Units; Male; Middle Aged; Sepsis; Vancomycin | 2016 |
Pediatric invasive disease due to Haemophilus influenzae serogroup A in Riyadh, Saudi Arabia: case series.
Topics: Anti-Bacterial Agents; Bacterial Capsules; Bacteriological Techniques; Cephalosporins; Cerebrospinal Fluid; Haemophilus influenzae; Haemophilus Vaccines; Humans; Infant; Male; Meningitis, Haemophilus; Saudi Arabia; Sepsis; Serogroup; Treatment Outcome; Vancomycin | 2016 |
Effects of inappropriate empirical antibiotic therapy on mortality in patients with healthcare-associated methicillin-resistant Staphylococcus aureus bacteremia: a propensity-matched analysis.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Cross Infection; Female; Hospital Mortality; Hospitals, University; Humans; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Odds Ratio; Propensity Score; Prospective Studies; Republic of Korea; Risk Factors; Sepsis; Vancomycin | 2016 |
Use of intravenous tigecycline in patients with severe Clostridium difficile infection: a retrospective observational cohort study.
Topics: Administration, Intravenous; Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Colectomy; Enterocolitis, Pseudomembranous; Female; Humans; Intraabdominal Infections; Male; Metronidazole; Middle Aged; Minocycline; Recurrence; Retrospective Studies; Sepsis; Tigecycline; Treatment Outcome; Vancomycin | 2016 |
Different Vancomycin Immunoassays Contribute to the Variability in Vancomycin Trough Measurements in Neonates.
Topics: Catheter-Related Infections; Female; Gestational Age; Humans; Immunoassay; Infant, Newborn; Pregnancy; Sepsis; Vancomycin | 2016 |
Duration of Systemic Inflammatory Response Syndrome Influences Serum Vancomycin Concentration in Patients With Sepsis.
Topics: Adult; Aged; Anti-Bacterial Agents; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Retrospective Studies; ROC Curve; Sepsis; Staphylococcal Infections; Systemic Inflammatory Response Syndrome; Time Factors; Vancomycin | 2016 |
Frequency of empiric antibiotic de-escalation in an acute care hospital with an established Antimicrobial Stewardship Program.
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Hospital Mortality; Humans; Length of Stay; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Retrospective Studies; Sepsis; Vancomycin | 2016 |
Development of a Physiologically Based Pharmacokinetic Modelling Approach to Predict the Pharmacokinetics of Vancomycin in Critically Ill Septic Patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Blood Proteins; Critical Illness; Cytochrome P-450 Enzyme System; Female; Hematocrit; Humans; Kidney; Liver; Male; Middle Aged; Models, Biological; Sepsis; Vancomycin; Young Adult | 2017 |
Efficacy of ceftaroline versus vancomycin in an experimental foreign-body and systemic infection model caused by biofilm-producing methicillin-resistant Staphylococcus epidermidis.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Biofilms; Ceftaroline; Cephalosporins; Disease Models, Animal; Female; Foreign Bodies; Methicillin Resistance; Mice, Inbred C57BL; Microbial Sensitivity Tests; Random Allocation; Sepsis; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome; Vancomycin | 2016 |
The association between vancomycin trough concentrations and acute kidney injury in the neonatal intensive care unit.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Female; Humans; Incidence; Infant, Newborn; Intensive Care Units, Neonatal; Intensive Care, Neonatal; Male; Retrospective Studies; Sepsis; Treatment Outcome; Vancomycin | 2017 |
Draft genome sequence of reduced teicoplanin-susceptible and vancomycin-heteroresistant methicillin-resistant Staphylococcus aureus from sepsis cases.
Topics: Anti-Bacterial Agents; Computational Biology; Genes, Bacterial; Genome, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Sepsis; Sequence Analysis, DNA; Staphylococcal Infections; Teicoplanin; Vancomycin; Vancomycin Resistance; Whole Genome Sequencing | 2017 |
Serious postpartum infection due to MRSA in an asymptomatic carrier: case report and review.
Topics: Abscess; Anti-Bacterial Agents; Anticoagulants; Carrier State; Cesarean Section; Cilastatin; Cilastatin, Imipenem Drug Combination; Drainage; Drug Combinations; Female; Heparin; Humans; Imipenem; Methicillin-Resistant Staphylococcus aureus; Pregnancy; Puerperal Infection; Pulmonary Embolism; Radiography; Sepsis; Staphylococcal Infections; Surgical Wound Infection; Thrombophlebitis; Vancomycin; Young Adult | 2008 |
Methicillin-resistant Staphylococcus aureus sepsis presenting with septic pulmonary emboli.
Topics: Abscess; Adult; CD4 Lymphocyte Count; HIV Infections; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Pulmonary Embolism; Pyelonephritis; Radiography; Sepsis; Staphylococcal Infections; Vancomycin | 2009 |
Acute thyroiditis due to septic emboli derived from infective endocarditis.
Topics: Adult; Anti-Bacterial Agents; Embolism; Endocarditis, Bacterial; Humans; Male; Sepsis; Thyroiditis, Suppurative; Vancomycin | 2008 |
Life-threatening complications associated with acute monocytic leukaemia after dental treatment.
Topics: Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Blast Crisis; Enterobacter cloacae; Enterobacteriaceae Infections; Fatal Outcome; Graft vs Host Disease; Humans; Jaw Diseases; Leukemia, Monocytic, Acute; Male; Osteonecrosis; Sepsis; Stem Cell Transplantation; Tooth Extraction; Vancomycin; Vancomycin Resistance | 2009 |
High imipenem blood concentrations associated with toxic encephalopathy in a patient with mild renal dysfunction.
Topics: Aged; Anti-Bacterial Agents; Catheter-Related Infections; Enterocolitis; Fatal Outcome; Female; Humans; Imipenem; Kidney Diseases; Neurotoxicity Syndromes; Sepsis; Staphylococcal Infections; Staphylococcus haemolyticus; Vancomycin | 2009 |
Community-acquired methicillin-resistant Staphylococcus aureus and Lemierre syndrome.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Community-Acquired Infections; Daptomycin; Female; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Sepsis; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2009 |
Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Base Sequence; Disease Models, Animal; DNA Primers; DNA, Viral; Drug Synergism; Female; Genes, Viral; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Microscopy, Electron, Transmission; Oxacillin; Protein Engineering; Recombinant Fusion Proteins; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus Phages; Vancomycin; Viral Proteins | 2010 |
A patient with Lemierre syndrome.
Topics: Anti-Bacterial Agents; Child; Clindamycin; Humans; Jugular Veins; Male; Pharyngitis; Sepsis; Syndrome; Thrombophlebitis; Vancomycin | 2010 |
Population pharmacokinetics of vancomycin in premature Malaysian neonates: identification of predictors for dosing determination.
Topics: Anti-Bacterial Agents; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Infant, Small for Gestational Age; Malaysia; Models, Biological; Monte Carlo Method; Retrospective Studies; Sepsis; Statistics, Nonparametric; Vancomycin | 2010 |
First detection of an invasive Staphylococcus aureus strain (D958) with reduced susceptibility to glycopeptides in Saudi Arabia.
Topics: Aged; Anti-Bacterial Agents; Bacterial Typing Techniques; Blood; Chromosomes, Bacterial; Cluster Analysis; DNA Fingerprinting; DNA, Bacterial; Genes, Bacterial; Genotype; Humans; Lysostaphin; Male; Methicillin-Resistant Staphylococcus aureus; Microarray Analysis; Microbial Sensitivity Tests; Microbial Viability; Plasmids; Saudi Arabia; Sepsis; Serum; Staphylococcal Infections; Teicoplanin; Vancomycin; Vancomycin Resistance | 2010 |
Antithymocyte globulin-induced acute lung injury during transplantation for aplastic anemia.
Topics: Acute Lung Injury; Anemia, Aplastic; Animals; Anti-Bacterial Agents; Antilymphocyte Serum; Bacterial Infections; Bone Marrow Transplantation; Child; Cyclophosphamide; Horses; Humans; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Transplantation Conditioning; Vancomycin; Vidarabine | 2011 |
Optimising vancomycin doses in continuous infusion for septic patients.
Topics: Anti-Bacterial Agents; Creatinine; Dose-Response Relationship, Drug; Humans; Infusions, Intravenous; Sepsis; Vancomycin | 2011 |
A seven-year survey of management of coagulase-negative staphylococcal sepsis in the neonatal intensive care unit: vancomycin may not be necessary as empiric therapy.
Topics: Anti-Bacterial Agents; Cefazolin; Coagulase; Female; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Longitudinal Studies; Male; Retrospective Studies; Sepsis; Staphylococcal Infections; Staphylococcus; Treatment Outcome; Vancomycin | 2011 |
Are gentamicin and/or vancomycin associated with ototoxicity in the neonate? A retrospective audit.
Topics: Anti-Bacterial Agents; Clinical Audit; Cochlear Implants; Dose-Response Relationship, Drug; Gentamicins; Hearing Loss; Hearing Tests; Humans; Incidence; Infant, Newborn; Intensive Care Units, Neonatal; Retrospective Studies; Risk Factors; Sepsis; Vancomycin | 2011 |
Initial dosing of vancomycin in critically ill patients.
Topics: Anti-Bacterial Agents; APACHE; Critical Illness; Dose-Response Relationship, Drug; Humans; Infusions, Intravenous; Sepsis; Vancomycin | 2011 |
The microbiology of secondary and postoperative pancreatic infections: implications for antimicrobial management.
Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Bacterial Infections; Cross Infection; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Male; Methicillin; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Mycoses; Pancreatectomy; Pancreatic Pseudocyst; Pancreatitis; Pancreatitis, Acute Necrotizing; Reoperation; Retrospective Studies; Risk Factors; Sepsis; Surgical Wound Infection; Tennessee; Vancomycin; Vancomycin Resistance | 2011 |
Vancomycin for meticillin-resistant Staphylococcus aureus (MRSA) infections in the Intensive Care Unit: the sunset boulevard of a gold standard?
Topics: Anti-Bacterial Agents; Bacterial Infections; Humans; Sepsis; Vancomycin | 2011 |
Infection of pacemaker lead by penicillin-resistant Streptococcus Pneumoniae.
Topics: Aged; Anti-Bacterial Agents; Device Removal; Drug Administration Schedule; Endocarditis, Bacterial; Humans; Male; Pacemaker, Artificial; Penicillin Resistance; Pneumococcal Infections; Recurrence; Sepsis; Streptococcus pneumoniae; Treatment Outcome; Vancomycin | 2011 |
[Actual aspects of sepsis].
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitals; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Retrospective Studies; Russia; Sepsis; Vancomycin | 2011 |
[Maculo-papular exanthem with acute renal failure. Drug-induced hypersensitivity syndrome].
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Aortic Valve; Aza Compounds; Biopsy; Diagnosis, Differential; Drug Eruptions; Drug Therapy, Combination; Endocarditis, Bacterial; Eosinophilia; Fluoroquinolones; Glucocorticoids; Humans; Kidney; Legionnaires' Disease; Male; Meropenem; Moxifloxacin; Nephritis, Interstitial; Quinolines; Sepsis; Skin; Thienamycins; Vancomycin | 2012 |
Efficacy of daptomycin versus vancomycin in an experimental model of foreign-body and systemic infection caused by biofilm producers and methicillin-resistant Staphylococcus epidermidis.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Catheters, Indwelling; Colony Count, Microbial; Daptomycin; Disease Models, Animal; Female; Humans; Liver; Methicillin Resistance; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Sepsis; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome; Vancomycin | 2012 |
[Antibiotic susceptibility of isolates from blood of patients in intensive care units of emergency medical service].
Topics: Acetamides; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Candida; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Infection Control; Intensive Care Units; Linezolid; Meropenem; Moscow; Oxazolidinones; Sepsis; Thienamycins; Vancomycin | 2011 |
Do we understand the impact of altered physiology, consequent interventions and resultant clinical scenarios in the intensive care unit? The antibiotic story.
Topics: Anti-Bacterial Agents; Body Fluid Compartments; Cardiac Output; Cardiac Surgical Procedures; Critical Illness; Female; Fluid Therapy; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Monitoring, Intraoperative; Pneumonia, Staphylococcal; Sepsis; Thermodilution; Vancomycin | 2011 |
Two cases of severe sepsis caused by Bacillus pumilus in neonatal infants.
Topics: Anti-Bacterial Agents; Bacillus; Female; Gram-Positive Bacterial Infections; Humans; Infant, Newborn; Male; Sepsis; Vancomycin | 2012 |
Determinants of early inadequate vancomycin concentrations during continuous infusion in septic patients.
Topics: Aged; Anti-Bacterial Agents; Area Under Curve; Cohort Studies; Creatinine; Female; Humans; Infusions, Parenteral; Intensive Care Units; Male; Middle Aged; Predictive Value of Tests; Retrospective Studies; ROC Curve; Sepsis; Severity of Illness Index; Time Factors; Vancomycin | 2012 |
Methicillin-resistant Staphylococcus capitis with reduced vancomycin susceptibility causes late-onset sepsis in intensive care neonates.
Topics: Humans; Infant, Newborn; Intensive Care, Neonatal; Methicillin Resistance; Retrospective Studies; Sepsis; Staphylococcus; Vancomycin | 2012 |
Augmented renal clearance in septic patients and implications for vancomycin optimisation.
Topics: Adult; Aged; Anti-Bacterial Agents; Critical Illness; Female; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Prospective Studies; Sepsis; Serum; Vancomycin | 2012 |
Reduced expression of PBP-2A by neonatal mecA-positive coagulase-negative staphylococci (CoNS) blood isolates: β-lactams are useful first-line agents for the treatment of neonatal CoNS sepsis, restricting the use of vancomycin.
Topics: Anti-Bacterial Agents; beta-Lactams; Coagulase; DNA, Bacterial; Gene Expression; Humans; Infant, Newborn; Methicillin Resistance; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Polymerase Chain Reaction; Sepsis; Staphylococcus; Vancomycin | 2012 |
Daptomycin experience in critical care patients: results from a registry.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Critical Care; Daptomycin; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Registries; Retrospective Studies; Sepsis; Treatment Outcome; Vancomycin; Young Adult | 2012 |
Continuous intravenous administration of vancomycin in medical intensive care unit patients.
Topics: Anti-Bacterial Agents; Area Under Curve; Case-Control Studies; Drug Administration Schedule; Drug Monitoring; Female; Germany; Humans; Infusions, Intravenous; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Sepsis; Vancomycin | 2013 |
Vancomycin removal during low-flux and high-flux extended daily hemodialysis in critically ill septic patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Humans; Male; Middle Aged; Renal Dialysis; Sepsis; Vancomycin | 2012 |
Successful management of methicillin-resistant Staphylococcus aureus bacteremia unresponsive to Vancomycin by adding fosfomycin: a case report.
Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Female; Fosfomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Sepsis; Vancomycin | 2012 |
[Antimicrobial dosing in critically ill patients requiring renal replacement therapy - maximize efficacy and minimize toxicity!].
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Critical Illness; Gentamicins; Humans; Renal Dialysis; Sepsis; Shock, Septic; Vancomycin | 2012 |
Persistent fever and atypical pathogen in blood culture ... Think beyond a skin contaminant!
Topics: Anti-Bacterial Agents; Corynebacterium; Corynebacterium Infections; Fever; Humans; Male; Middle Aged; Pulmonary Embolism; Sepsis; Vancomycin | 2013 |
Vancomycin pharmacokinetics during high-volume continuous venovenous hemofiltration in critically ill septic patients.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Area Under Curve; Critical Illness; Drug Monitoring; Female; Hemofiltration; Humans; Male; Middle Aged; Prospective Studies; Sepsis; Vancomycin | 2014 |
In vitro synergy of oxacillin and gentamicin against coagulase-negative staphylococci from blood cultures of neonates with late-onset sepsis.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Coagulase; Culture Media; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Gentamicins; Humans; Infant, Newborn; Microbial Sensitivity Tests; Oxacillin; Sepsis; Staphylococcal Infections; Staphylococcus; Vancomycin | 2013 |
Continuous infusion of vancomycin in septic patients receiving continuous renal replacement therapy.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Female; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Male; Middle Aged; Renal Replacement Therapy; Sepsis; Serum; Vancomycin | 2013 |
Methicillin-resistant Staphylococcus aureus-induced thrombo-inflammatory response is reduced with timely antibiotic administration.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Blood Coagulation; Cell-Derived Microparticles; Cytokines; Drug Administration Schedule; Humans; Inflammation; Inflammation Mediators; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Monocytes; Oxazolidinones; Sepsis; Staphylococcal Infections; Thrombin; Thrombosis; Time Factors; Vancomycin | 2013 |
Yoghurt biotherapy: contraindicated in immunosuppressed patients?
Topics: Adult; Anti-Bacterial Agents; Biological Therapy; Contraindications; Cyclophosphamide; Fatal Outcome; Female; Fludrocortisone; Humans; Immunocompromised Host; Immunosuppressive Agents; Lactobacillus; Opportunistic Infections; Sepsis; Sjogren's Syndrome; Staphylococcal Infections; Vancomycin; Yogurt | 2002 |
Lemierre's disease caused by co-infection of Arcanobacterium haemolyticum and Fusobacterium necrophorum: a case report.
Topics: Actinomycetales; Actinomycetales Infections; Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Fusobacterium Infections; Humans; Jugular Veins; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Thrombophlebitis; Vancomycin | 2002 |
Anti-septicaemic effect of polysaccharide from Panax ginseng by macrophage activation.
Topics: Animals; Anti-Bacterial Agents; Cytokines; Dose-Response Relationship, Drug; Female; Macrophage Activation; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Nitric Oxide; Nitrites; Panax; Phagocytosis; Polysaccharides; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Vancomycin | 2002 |
Evaluation and treatment of neonates with suspected late-onset sepsis: a survey of neonatologists' practices.
Topics: Bacterial Infections; Catheterization, Central Venous; Coagulase; Device Removal; Health Services Research; Humans; Infant, Newborn; Infection Control; Intensive Care Units, Neonatal; Neonatology; Practice Guidelines as Topic; Practice Patterns, Physicians'; Sepsis; Staphylococcal Infections; Staphylococcus; Vancomycin | 2002 |
Dose regimen for vancomycin not needing serum peak levels?
Topics: Anti-Bacterial Agents; Cohort Studies; Dose-Response Relationship, Drug; Gestational Age; Humans; Infant; Infant, Newborn; Intensive Care, Neonatal; Retrospective Studies; Sepsis; Vancomycin | 2002 |
A retrospective review of three antibiotic prophylaxis regimens for pediatric cardiac surgical patients.
Topics: Antibiotic Prophylaxis; Cardiac Surgical Procedures; Cefazolin; Drug Administration Schedule; Gentamicins; Humans; Infant; Postoperative Complications; Retrospective Studies; Sepsis; Surgical Wound Infection; Thoracotomy; Vancomycin | 2002 |
Resistant staphylococcal puerperal septicaemia susceptible to vancomycin.
Topics: Anti-Bacterial Agents; Bacteremia; Female; Humans; Micrococcus; Postpartum Period; Sepsis; Staphylococcus; Vancomycin | 1958 |
Staphylococcal septicaemia treated with vancomycin in the presence of chronic renal failure.
Topics: Anti-Bacterial Agents; Bacteremia; Kidney Diseases; Kidney Failure, Chronic; Sepsis; Staphylococcal Infections; Vancomycin | 1960 |
PROLONGED FATAL STAPHYLOCOCCEMIA; A CASE REPORT.
Topics: Acromegaly; Bacitracin; Chloramphenicol; Erythromycin; Hypopituitarism; Penicillins; Polymyxins; Pseudomonas Infections; Ristocetin; Sepsis; Staphylococcal Infections; Toxicology; Vancomycin | 1964 |
STAPHYLOCOCCAL PNEUMONIA IN CHILDHOOD.
Topics: Abscess; Anti-Bacterial Agents; Bacitracin; Bronchial Fistula; Chloramphenicol; Empyema; Erythromycin; Humans; Kanamycin; Novobiocin; Penicillins; Pleural Effusion; Pneumonia; Pneumonia, Staphylococcal; Pneumothorax; Sepsis; Staphylococcal Infections; Tetracycline; Vancomycin | 1964 |
EVALUATION OF ANTIBIOTIC PROPHYLAXIS AND GAMMA-GLOBULIN, PLASMA, ALBUMIN AND SALINE-SOLUTION THERAPY IN SEVERE BURNS. BACTERIOLOGIC AND IMMUNOLOGIC STUDIES.
Topics: Adolescent; Anti-Bacterial Agents; Antibiotic Prophylaxis; Burns; Child; Chloramphenicol; Colistin; Erythromycin; Escherichia coli Infections; gamma-Globulins; Humans; Immune Sera; Infant; Infant, Newborn; Kanamycin; Novobiocin; Polymyxins; Proteus Infections; Pseudomonas Infections; Salmonella Infections; Sepsis; Serum Albumin; Shigella; Sodium Chloride; Solutions; Staphylococcal Infections; Streptococcal Infections; Tetracycline; Vancomycin | 1964 |
Treatment of staphylococcal septicemia with vancomycin: report of thirty-three cases.
Topics: Anti-Bacterial Agents; Bacteremia; Humans; Sepsis; Staphylococcal Infections; Vancomycin | 1960 |
Aminoglycoside and vancomycin serum concentration monitoring and mortality due to neonatal sepsis in Saudi Arabia.
Topics: Amikacin; Anti-Bacterial Agents; Gentamicins; Humans; Incidence; Infant, Newborn; Retrospective Studies; Saudi Arabia; Sepsis; Vancomycin | 2003 |
The routine microbiological screening of central venous catheters in home parenteral nutrition patients.
Topics: Candidiasis; Catheterization, Central Venous; Female; Humans; Male; Middle Aged; Parenteral Nutrition, Home Total; Sepsis; Staphylococcal Infections; Vancomycin | 2004 |
Septic pelvic thrombophlebitis and preeclampsia are related disorders.
Topics: Anti-Bacterial Agents; Body Mass Index; Chorioamnionitis; Delivery, Obstetric; Female; Fever; Fibrinolytic Agents; Follow-Up Studies; Gram-Positive Bacterial Infections; HELLP Syndrome; Heparin; Humans; Incidence; Maternal Welfare; Mississippi; Pelvic Inflammatory Disease; Pelvis; Pre-Eclampsia; Pregnancy; Pregnancy Outcome; Puerperal Infection; Retrospective Studies; Sepsis; Thrombophlebitis; Trial of Labor; Vancomycin | 2004 |
Pneumococcal-associated purpura fulminans in a healthy infant.
Topics: Cefotaxime; Combined Modality Therapy; Debridement; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fever; Foot; Gangrene; Hand; Humans; IgA Vasculitis; Immunocompetence; Infant; Ischemia; Male; Physical Therapy Modalities; Plasma; Plastic Surgery Procedures; Pneumococcal Infections; Pneumonia, Pneumococcal; Sepsis; Skin Transplantation; Vancomycin | 2004 |
Chryseobacterium meningosepticum infections in a dialysis unit.
Topics: Chryseobacterium; Ciprofloxacin; Cross Infection; Equipment Contamination; Flavobacteriaceae Infections; Hemodialysis Units, Hospital; Hospitals, General; Hospitals, Teaching; Humans; Peritoneal Dialysis; Peritonitis; Retrospective Studies; Sepsis; Sri Lanka; Vancomycin | 2004 |
Features of invasive staphylococcal disease in neonates.
Topics: Age of Onset; Anti-Bacterial Agents; Catheters, Indwelling; Coagulase; Cohort Studies; Drug Resistance, Multiple; Female; Gentamicins; Gestational Age; Humans; Hypotension; Hypoxia; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Male; Multivariate Analysis; Retrospective Studies; Risk Factors; Sepsis; Staphylococcal Infections; Staphylococcus; Vancomycin | 2004 |
Effect of granulocyte colony-stimulating factor in experimental methicillin resistant Staphylococcus aureus sepsis.
Topics: Animals; Anti-Bacterial Agents; Drug Therapy, Combination; Granulocyte Colony-Stimulating Factor; Male; Methicillin Resistance; Mice; Mice, Inbred BALB C; Random Allocation; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2004 |
RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Cefazolin; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Imipenem; Male; Mice; Mice, Inbred BALB C; Oligopeptides; Random Allocation; Sensitivity and Specificity; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Vancomycin | 2005 |
Unilateral shoulder swelling in a preterm neonate.
Topics: Anti-Bacterial Agents; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Osteomyelitis; Sepsis; Staphylococcal Infections; Vancomycin | 2005 |
[Case of congestive heart failure associated with hypereosinophilia developed during antibiotics treatment].
Topics: Aged, 80 and over; Anti-Bacterial Agents; Drug Resistance, Multiple; Drug Therapy, Combination; Enterococcus; Gram-Positive Bacterial Infections; Heart Failure; Humans; Hypereosinophilic Syndrome; Male; Methicillin Resistance; Methylprednisolone; Sepsis; Staphylococcal Infections; Teicoplanin; Treatment Outcome; Vancomycin | 2005 |
A case of intractable methicillin-resistant Staphylococcus aureus sepsis after an operation for tetralogy of Fallot that was successfully resolved by combined treatment with vancomycin and urokinase.
Topics: Biofilms; Drug Therapy, Combination; Female; Humans; Infant; Methicillin Resistance; Microbial Sensitivity Tests; Postoperative Complications; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Tetralogy of Fallot; Urokinase-Type Plasminogen Activator; Vancomycin | 2006 |
Are antiseptic-coated central venous catheters effective in a real-world setting?
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Local; Antisepsis; Catheterization, Central Venous; Catheters, Indwelling; Chlorhexidine; Cross Infection; Hospitals, University; Humans; Poisson Distribution; Regression Analysis; Sepsis; Silver Sulfadiazine; Treatment Outcome; Vancomycin | 2006 |
Community-acquired meningitis and sepsis caused by Chryseobacterium meningosepticum in a patient diagnosed with thalassemia major.
Topics: Adolescent; Anti-Bacterial Agents; beta-Thalassemia; Chryseobacterium; Community-Acquired Infections; Flavobacteriaceae Infections; Humans; Male; Meningitis, Bacterial; Sepsis; Vancomycin | 2006 |
Coagulase negative Staphylococci from blood cultures: contaminants or pathogens?
Topics: Adult; Aged; Anti-Bacterial Agents; Coagulase; Cross Infection; Drug Resistance; Female; Hospitals, University; Humans; Jamaica; Male; Middle Aged; Sepsis; Staphylococcal Infections; Staphylococcus; Vancomycin | 2006 |
Bacterial meningitis from Rothia mucilaginosa in patients with malignancy or undergoing hematopoietic stem cell transplantation.
Topics: Actinomycetales Infections; Adolescent; Anti-Bacterial Agents; Ceftazidime; Cerebrospinal Fluid Shunts; Child; Cord Blood Stem Cell Transplantation; Drug Therapy, Combination; Fatal Outcome; Female; Humans; Immunocompromised Host; Leukemia, Megakaryoblastic, Acute; Male; Meningitis, Bacterial; Meropenem; Micrococcaceae; Opportunistic Infections; Postoperative Complications; Rifampin; Sepsis; Thienamycins; Vancomycin | 2008 |
[Sepsis in the sphenoiditis patient].
Topics: Abscess; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Humans; Imipenem; Middle Aged; Radiography; Sepsis; Sphenoid Sinus; Sphenoid Sinusitis; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2007 |
Vancomycin pharmacokinetics in preterm infants.
Topics: Anti-Bacterial Agents; Half-Life; Humans; Infant, Newborn; Infant, Premature, Diseases; Metabolic Clearance Rate; Prospective Studies; Sepsis; Vancomycin | 2007 |
Hematogenous methicillin-resistant Staphylococcus aureus spondylodiscitis.
Topics: Aged; Anti-Infective Agents; Discitis; Female; Humans; Leukocyte Count; Male; Methicillin Resistance; Middle Aged; Neurosurgical Procedures; Recurrence; Retrospective Studies; Risk Factors; Sepsis; Sex Distribution; Spine; Staphylococcal Infections; Staphylococcus aureus; Survival Rate; Vancomycin | 2007 |
Cervicothoracolumbar spinal epidural abscess and cerebral salt wasting.
Topics: Adolescent; Anti-Bacterial Agents; Ceftriaxone; Cervical Vertebrae; Epidural Abscess; Gentamicins; Humans; Hyponatremia; Hypotension; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Sepsis; Staphylococcal Infections; Thoracic Vertebrae; Vancomycin | 2009 |
Therapeutic drug monitoring of vancomycin in severe sepsis and septic shock.
Topics: Anti-Bacterial Agents; Drug Monitoring; Fluorescence Polarization Immunoassay; Humans; Infusions, Intravenous; Intensive Care Units; Models, Biological; Prospective Studies; Sepsis; Severity of Illness Index; Shock, Septic; Time Factors; Vancomycin | 2008 |
In vitro activity of cefmenoxime, cefotaxime, latamoxef, cefazolin, nafcillin and vancomycin against 53 endocarditis and bacteremic strains of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cefazolin; Cefmenoxime; Cefotaxime; Endocarditis, Bacterial; Humans; Microbial Sensitivity Tests; Moxalactam; Nafcillin; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1984 |
In vivo v in vitro susceptibility of enterococcus to trimethoprim-sulfamethoxazole. A pitfall.
Topics: Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillin Resistance; Penicillins; Sepsis; Streptococcal Infections; Streptococcus; Streptomycin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Vancomycin | 1984 |
Staphylococcus epidermidis sepsis in pediatric patients: clinical and therapeutic considerations.
Topics: Adolescent; Catheters, Indwelling; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Male; Sepsis; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1984 |
Staphylococcus epidermidis bacteremia in neonates: further observations and the occurrence of focal infection.
Topics: Catheters, Indwelling; Drug Resistance, Microbial; Focal Infection; Humans; Infant; Infant, Newborn; Sepsis; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1984 |
Piperacillin plus vancomycin in the therapy of febrile episodes in cancer patients.
Topics: Bacterial Infections; Drug Combinations; Fever; Humans; Leukocyte Count; Neoplasms; Neutrophils; Piperacillin; Sepsis; Vancomycin | 1984 |
The clinical significance of gastrointestinal decontamination in the occurrence of endogenous infections.
Topics: Adult; Aged; Bacteria, Anaerobic; Bacterial Infections; Female; Humans; Intestines; Leukemia; Male; Middle Aged; Nystatin; Polymyxin B; Sepsis; Vancomycin | 1984 |
Vancomycin treatment of bacteremia caused by oxacillin-resistant Staphylococcus aureus: comparison with beta-lactam antibiotic treatment of bacteremia caused by oxacillin-sensitive Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cross Infection; Female; Humans; Male; Middle Aged; Oxacillin; Penicillin Resistance; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1983 |
Vancomycin therapy of oxacillin-resistant Staphylococcus aureus infections.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Humans; Middle Aged; Oxacillin; Penicillin Resistance; Respiratory Tract Infections; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1983 |
Vancomycin serum levels and toxicity in chronic hemodialysis patients with Staphylococcus aureus bacteremia.
Topics: Chronic Disease; Dose-Response Relationship, Drug; Hearing Tests; Humans; Kinetics; Prospective Studies; Renal Dialysis; Sepsis; Staphylococcal Infections; Vancomycin | 1983 |
Bacteremia caused by a previously unidentified species of rapidly growing Mycobacterium successfully treated with vancomycin.
Topics: Aged; Female; Humans; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium Infections; Sepsis; Vancomycin | 1983 |
Staphylococcus epidermidis septicemia in children with leukemia and lymphoma.
Topics: Adolescent; Antineoplastic Agents; Catheterization; Child; Child, Preschool; Drainage; Drug Resistance, Microbial; Female; Humans; Immunosuppressive Agents; Leukemia; Lymphoma; Male; Microbial Sensitivity Tests; Neutropenia; Sepsis; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1984 |
An arm infection after abdominal gunshot wound.
Topics: Abdominal Injuries; Adult; Arm; Cefazolin; Humans; Male; Microbial Sensitivity Tests; Nafcillin; Sepsis; Staphylococcal Infections; Tobramycin; Vancomycin; Wounds, Gunshot | 1981 |
Bacillus cereus septicemia in a drug addict: case report.
Topics: Adult; Bacillus cereus; Humans; Male; Sepsis; Substance-Related Disorders; Vancomycin | 1982 |
Sepsis with coagulase-negative staphylococci in critically ill newborns.
Topics: Coagulase; Cross Infection; Drug Resistance, Microbial; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Intensive Care Units, Neonatal; Male; Sepsis; Staphylococcal Infections; Staphylococcus; Vancomycin | 1983 |
Coagulase-negative staphylococcal bacteremia in patients receiving immunosuppressive therapy.
Topics: Adolescent; Adult; Aged; Catheterization; Cefazolin; Child; Female; Humans; Immunosuppression Therapy; Infusions, Parenteral; Male; Microbial Sensitivity Tests; Middle Aged; Sepsis; Staphylococcal Infections; Vancomycin | 1983 |
Bacteremia due to methicillin-resistant Staphylococcus aureus.
Topics: Cross Infection; Female; Humans; Male; Methicillin; Middle Aged; Penicillin Resistance; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1982 |
[Treatment of severe infections and septicemia caused by S. aureus (author's transl)].
Topics: Anti-Bacterial Agents; Cefamandole; Cephalosporins; Drug Therapy, Combination; Humans; Oxacillin; Penicillin Resistance; Sepsis; Staphylococcal Infections; Tobramycin; Vancomycin | 1982 |
Prophylactic non-absorbable antibiotics in leukaemic patients.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Drug Resistance, Microbial; Feces; Female; Humans; Kanamycin; Leukemia; Male; Middle Aged; Neutropenia; Nystatin; Sepsis; Vancomycin | 1980 |
[Vancomycin: treatment of staphylococcal septicemias and pseudomembranous colitis].
Topics: Enterocolitis, Pseudomembranous; Humans; Sepsis; Staphylococcal Infections; Vancomycin | 1982 |
Vancomycin therapy for methicillin-resistant Staphylococcus aureus.
Topics: Dose-Response Relationship, Drug; Humans; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1982 |
Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center.
Topics: Academic Medical Centers; Adult; Anti-Bacterial Agents; Cross Infection; Endocarditis, Bacterial; Female; Humans; Male; Methicillin; Michigan; Middle Aged; Nafcillin; Penicillin Resistance; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1982 |
Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia.
Topics: Adult; Agranulocytosis; Female; Humans; Leukemia; Male; Risk; Sepsis; Skin; Staphylococcal Infections; Staphylococcus; Vancomycin | 1982 |
Graft infection and bacteremia with Listeria monocytogenes in a patient receiving hemodialysis.
Topics: Blood Vessel Prosthesis; Female; Humans; Listeriosis; Microbial Sensitivity Tests; Middle Aged; Renal Dialysis; Sepsis; Vancomycin | 1982 |
Speciation and antibiotic susceptibility patterns of coagulase-negative staphylococci.
Topics: Anti-Bacterial Agents; Cerebrospinal Fluid; Drug Resistance, Microbial; Heart Valves; Humans; Microbial Sensitivity Tests; Sepsis; Staphylococcal Infections; Staphylococcus; Vancomycin | 1982 |
[Multiresistant Staphylococcus epidermidis septicemia with meningeal localization. Cure by general and intrathecal administration of vancomycin].
Topics: Female; Humans; Middle Aged; Sepsis; Staphylococcal Infections; Vancomycin | 1981 |
Infections caused by group F streptococci.
Topics: Adult; Amputation, Surgical; Endocarditis, Bacterial; Female; Foot Diseases; Humans; Male; Middle Aged; Penicillin G; Sepsis; Skin Ulcer; Streptococcal Infections; Streptococcus; Vancomycin | 1981 |
Vancomycin pharmacokinetics and dosing in premature neonates.
Topics: Anti-Bacterial Agents; Drug Administration Schedule; Enterocolitis, Pseudomembranous; Humans; Infant, Newborn; Infant, Premature, Diseases; Infusions, Intravenous; Sepsis; Staphylococcal Infections; Vancomycin | 1995 |
Morbidity using subcutaneous ports and efficacy of vancomycin flushing in cancer.
Topics: Adolescent; Age Factors; Bacterial Infections; Catheters, Indwelling; Child; Child, Preschool; Equipment Contamination; Equipment Failure; Female; Humans; Infant; Male; Neoplasms; Risk Factors; Sepsis; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1995 |
Vancomycin-resistant Enterococcus faecium sepsis following persistent colonization.
Topics: Adult; Drug Resistance, Microbial; Enterococcus faecium; Fatal Outcome; Female; Gram-Positive Bacterial Infections; Humans; Leukemia, Myeloid, Acute; Sepsis; Vancomycin | 1995 |
[Fever and lung abscesses in anorexia nervosa after infusion therapy].
Topics: Adult; Anorexia Nervosa; Catheterization, Central Venous; Ceftazidime; Diagnosis, Differential; Drug Therapy, Combination; Echocardiography, Doppler, Color; Endocarditis, Bacterial; Female; Fever of Unknown Origin; Follow-Up Studies; Humans; Lung Abscess; Opportunistic Infections; Parenteral Nutrition, Total; Sepsis; Staphylococcal Infections; Tricuspid Valve Insufficiency; Vancomycin | 1994 |
[Microbiological and clinical studies of vancomycin resistant Leuconostoc spp. and Pediococcus spp. isolated from septicemia patients].
Topics: Aged; Cholangitis; Diabetes Complications; Diabetes Mellitus; Drug Resistance, Microbial; Esophageal Neoplasms; Humans; Leuconostoc; Male; Middle Aged; Pediococcus; Sepsis; Vancomycin | 1994 |
Catheter-related septicemia caused by a vancomycin-resistant Coryneform CDC group A-5.
Topics: Actinomycetales; Actinomycetales Infections; Catheterization, Central Venous; Child; Drug Resistance, Microbial; Humans; Male; Sepsis; Vancomycin | 1994 |
[Sepsis caused by coagulase-negative Staphylococcus in the newborn infant. Clinical and therapeutic aspects].
Topics: Coagulase; Cross Infection; Female; Humans; Incidence; Infant, Newborn; Intensive Care Units, Neonatal; Male; Sepsis; Spain; Staphylococcal Infections; Vancomycin | 1993 |
[Two cases of gram-positive sepsis successfully treated with vancomycin in combination with imipenem or cilastatin].
Topics: Adolescent; Cilastatin; Drug Therapy, Combination; Female; Gram-Positive Bacterial Infections; Humans; Imipenem; Male; Sepsis; Vancomycin | 1996 |
Vancomycin-induced neutropenia treated with granulocyte colony-stimulating factor during home intravenous infusion therapy.
Topics: Adult; General Surgery; Granulocyte Colony-Stimulating Factor; Humans; Male; Neutropenia; Osteomyelitis; Sepsis; Staphylococcal Infections; Vancomycin | 1996 |
Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality.
Topics: Adult; Aged; Aged, 80 and over; Bacteremia; Cohort Studies; Drug Resistance, Microbial; Enterococcus; Female; Humans; Male; Middle Aged; Sepsis; Shock, Septic; Vancomycin | 1996 |
Serious infections caused by multiply-resistant Enterococcus faecium.
Topics: Abdomen; Adult; Anti-Bacterial Agents; Bacteremia; Drug Resistance, Multiple; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Immunocompetence; Liver Transplantation; Male; Recurrence; Sepsis; Vancomycin | 1995 |
Thrombocytopenia induced by vancomycin-dependent platelet antibody.
Topics: Aged; Anti-Bacterial Agents; Blood Platelets; Female; Humans; Sepsis; Staphylococcal Infections; Thrombocytopenia; Vancomycin | 1997 |
Evaluation of a sparse sampling strategy for determining vancomycin pharmacokinetics in preterm neonates: application of optimal sampling theory.
Topics: Aminoglycosides; Anti-Bacterial Agents; Female; Half-Life; Humans; Infant, Newborn; Infant, Premature; Infusions, Intravenous; Intensive Care Units, Neonatal; Male; Metabolic Clearance Rate; Predictive Value of Tests; Sampling Studies; Sepsis; Vancomycin | 1997 |
Therapeutic efficacy of BO-3482, a novel dithiocarbamate carbapenem, in mice infected with methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Carbapenems; Dipeptidases; Imipenem; Kidney; Methicillin Resistance; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Muscle, Skeletal; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1997 |
The relationship between the use of flucloxacillin, vancomycin, aminoglycosides and ciprofloxacin and the susceptibility patterns of coagulase-negative staphylococci recovered from blood cultures.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Ciprofloxacin; Coagulase; Drug Resistance, Microbial; Floxacillin; Humans; Microbial Sensitivity Tests; Penicillins; Sepsis; Streptococcal Infections; Streptococcus; Vancomycin | 1997 |
First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital.
Topics: Anti-Bacterial Agents; Child, Preschool; Female; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Opportunistic Infections; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1998 |
Should we use vancomycin as prophylaxis to prevent neonatal nosocomial coagulase-negative staphylococcal septicemia?
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Coagulase; Cross Infection; Humans; Infant, Newborn; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1998 |
Successful vancomycin desensitization in a patient with end-stage renal disease and anaphylactic shock to vancomycin.
Topics: Anaphylaxis; Anti-Bacterial Agents; Desensitization, Immunologic; Female; Humans; Kidney Failure, Chronic; Middle Aged; Sepsis; Vancomycin | 1998 |
Clinical outcome of cephalothin versus vancomycin therapy in the treatment of coagulase-negative staphylococcal septicemia in neonates: relation to methicillin resistance and mec A gene carriage of blood isolates.
Topics: Anti-Bacterial Agents; Cephalosporins; Cephalothin; Coagulase; Genes, Bacterial; Humans; Infant; Infant, Newborn; Methicillin Resistance; Retrospective Studies; Sepsis; Staphylococcal Infections; Staphylococcus; Vancomycin | 1999 |
Cyclosporine treatment of psoriatic erythroderma complicated by bacterial sepsis.
Topics: Acitretin; Anti-Bacterial Agents; Cefazolin; Cephalosporins; Cyclosporine; Dermatitis, Exfoliative; Dermatologic Agents; Humans; Immunosuppressive Agents; Keratolytic Agents; Male; Middle Aged; Psoriasis; Sepsis; Staphylococcal Infections; Streptococcal Infections; Vancomycin | 1999 |
In-vitro and in-vivo antibacterial activity of BI 397, a new semi-synthetic glycopeptide antibiotic.
Topics: Animals; Anti-Bacterial Agents; Endocarditis, Bacterial; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Mice; Microbial Sensitivity Tests; Pneumonia, Pneumococcal; Rats; Sepsis; Teicoplanin; Vancomycin | 1999 |
Septicemia in neutropenic patients infected with Clostridium tertium resistant to cefepime and other expanded-spectrum cephalosporins.
Topics: Aged; Anti-Bacterial Agents; Cefepime; Cephalosporin Resistance; Cephalosporins; Clostridium; Clostridium Infections; Humans; Male; Middle Aged; Neutropenia; Opportunistic Infections; Sepsis; Vancomycin | 1999 |
Rationing antibiotic use in neonatal units.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Decision Making; Drug Resistance, Microbial; Floxacillin; Health Care Rationing; Humans; Infant, Newborn; Intensive Care, Neonatal; Penicillins; Sepsis; Vancomycin | 2000 |
Vancomycin dosage requirements among pediatric intensive care unit patients with normal renal function.
Topics: Anti-Bacterial Agents; Child; Child, Preschool; Humans; Infant; Intensive Care Units, Pediatric; Kidney Function Tests; Sepsis; Vancomycin | 2000 |
Vancomycin population pharmacokinetics in neonates.
Topics: Analysis of Variance; Anti-Bacterial Agents; Birth Weight; Drug Administration Schedule; Drug Monitoring; Gestational Age; Humans; Infant, Newborn; Infusions, Intravenous; Intensive Care Units, Neonatal; Prospective Studies; Retrospective Studies; Sepsis; Vancomycin | 2000 |
[Two cases of methicillin-resistant Staphylococcus aureus (MRSA) sepsis following craniotomy].
Topics: Adult; Aged; Alanine; Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Craniotomy; Dibekacin; Drug Therapy, Combination; Female; Humans; Male; Meningeal Neoplasms; Meningioma; Methicillin Resistance; Postoperative Complications; Sepsis; Staphylococcal Infections; Sulbactam; Thienamycins; Treatment Outcome; Vancomycin | 2000 |
Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995-1998.
Topics: Anti-Bacterial Agents; Bacterial Capsules; Cefotaxime; Chloramphenicol; Clindamycin; Drug Resistance, Microbial; Erythromycin; Female; Humans; Infant, Newborn; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Sepsis; Serotyping; Streptococcal Infections; Streptococcus agalactiae; Tetracycline; Vancomycin | 2000 |
Analysis of 42 cases of septicemia caused by an epidemic strain of methicillin-resistant Staphylococcus aureus: evidence of resistance to vancomycin.
Topics: Animals; Anti-Bacterial Agents; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Microbial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Methicillin; Mice; Microbial Sensitivity Tests; Microscopy, Electron; Penicillins; Prevalence; Retrospective Studies; Rifampin; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Virulence | 2000 |
Successful medical treatment of acute bilateral emphysematous pyelonephritis.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Combined Modality Therapy; Diabetes Mellitus, Type 2; Emphysema; Hemofiltration; Humans; Male; Meropenem; Middle Aged; Pyelonephritis; Sepsis; Thienamycins; Treatment Outcome; Vancomycin | 2000 |
Fulminant late-onset sepsis in a neonatal intensive care unit, 1988-1997, and the impact of avoiding empiric vancomycin therapy.
Topics: Abnormalities, Multiple; Bacterial Infections; Candidiasis; Comorbidity; Cross Infection; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Meningitis; North Carolina; Oxacillin; Retrospective Studies; Sepsis; Staphylococcal Infections; Vancomycin; Virginia | 2000 |
Effects of adjunctive treatment with combined cytokines in a neutropenic mouse model of multidrug-resistant Enterococcus faecalis septicemia.
Topics: Animals; Anti-Bacterial Agents; Cytokines; Drug Resistance, Multiple; Drug Therapy, Combination; Enterococcus faecalis; Female; Gentamicins; Gram-Positive Bacterial Infections; Granulocyte-Macrophage Colony-Stimulating Factor; Interferon-gamma; Mice; Neutropenia; Recombinant Proteins; Sepsis; Vancomycin | 2001 |
[Fatal septicemia from Staphylococcus aureus resistance to glycopeptides].
Topics: Aged; Anti-Bacterial Agents; Drug Resistance, Microbial; Fatal Outcome; Humans; Male; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2001 |
Evidence of less severe aortic valve destruction after treatment of experimental staphylococcal endocarditis with vancomycin and dexamethasone.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Aortic Valve; Dexamethasone; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Methicillin Resistance; Microbial Sensitivity Tests; Rabbits; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Survival Analysis; Vancomycin | 2001 |
[Nosocomial catheter-related sepsis secondary to central venous catheters].
Topics: Amikacin; Anti-Bacterial Agents; Catheterization, Central Venous; Cross Infection; Drug Resistance, Microbial; Female; Gram-Negative Aerobic Bacteria; Gram-Positive Cocci; Humans; Male; Middle Aged; Retrospective Studies; Sepsis; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin | 1999 |
The use of linezolid in the treatment of vancomycin-resistant enterococcal septicaemia in two patients with burn injuries.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Burns; Drug Resistance, Microbial; Enterococcus; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Sepsis; Vancomycin | 2002 |
Staphylococcus warneri septicemia in preterm neonates - a reminder.
Topics: Cefotaxime; Cross Infection; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Infant, Premature; Sepsis; Staphylococcal Infections; Vancomycin | 2002 |
A new type of penicillin resistance of Staphylococcus aureus.
Topics: Adult; Autolysis; Bacteriolysis; Cephalothin; Child, Preschool; Drug Tolerance; Endocarditis, Bacterial; Female; Humans; Infant; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Nafcillin; Osteomyelitis; Penicillin Resistance; Penicillins; Pneumonia, Staphylococcal; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1977 |
Staphylococcus aureus endocarditis. Combined therapy with vancomycin and rifampin.
Topics: Blood; Child, Preschool; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Humans; Infant; Male; Methicillin; Penicillin Resistance; Rifampin; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1978 |
Infection due to Corynebacterium species in marrow transplant patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Anti-Bacterial Agents; Bacteriological Techniques; Bone Marrow Transplantation; Child; Child, Preschool; Corynebacterium; Corynebacterium Infections; Female; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Mortality; Proctitis; Respiratory Tract Infections; Retrospective Studies; Sepsis; Sex Factors; Skin Diseases, Infectious; Vancomycin | 1979 |
Corynebacterium sepsis in oncology patients. Predisposing factors, diagnosis, and treatment.
Topics: Adult; Aged; Antineoplastic Agents; Corynebacterium Infections; Disease Susceptibility; Female; Humans; Immunity; Male; Middle Aged; Neoplasms; Sepsis; Vancomycin | 1977 |
Synergism with aminoglycosides of penicillin, ampicillin and vancomycin against non-enterococcal group-D streptococci and viridans streptococci.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Blood; Drug Synergism; Endocarditis, Bacterial; Humans; Penicillin Resistance; Penicillins; Sepsis; Species Specificity; Streptococcaceae; Streptococcus; Vancomycin | 1977 |
Persistent bacteremia in staphylococcal endocarditis.
Topics: Adult; Aged; Cephalosporins; Clindamycin; Drug Resistance, Microbial; Endocarditis, Bacterial; Female; Humans; Male; Middle Aged; Penicillin Resistance; Sepsis; Staphylococcal Infections; Vancomycin | 1978 |
Staphylococcal sepsis in patients on chronic hemodialysis regimens: intravenous treatment with vancomycin given once weekly.
Topics: Adult; Blood Bactericidal Activity; Drug Administration Schedule; Humans; Infusions, Parenteral; Kidney Failure, Chronic; Male; Middle Aged; Penicillin Resistance; Renal Dialysis; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1976 |
[Use of vancomycin in treating staphylococcal septicemia in newborns].
Topics: Female; Humans; Infant, Newborn; Infant, Premature; Male; Microbial Sensitivity Tests; Sepsis; Staphylococcal Infections; Vancomycin | 1992 |
[Demethyl-vancomycin in treatment of resistant staphylococcal infections. A clinical evaluation].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Female; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1992 |
[Septicemia caused by MRSA].
Topics: Aminoglycosides; Anti-Bacterial Agents; Catheterization; Dibekacin; Equipment Contamination; Humans; Methicillin Resistance; Prognosis; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1992 |
Septicaemia caused by Pediococcus pentosaceus: a new opportunistic pathogen.
Topics: Ampicillin; Drug Resistance, Microbial; Female; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Immune Tolerance; Middle Aged; Opportunistic Infections; Pediococcus; Sepsis; Vancomycin | 1991 |
American Heart Association updates recommendations for prevention of infective endocarditis.
Topics: American Heart Association; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Clindamycin; Dental Care for Disabled; Endocarditis, Bacterial; Erythromycin; Humans; Premedication; Sepsis; Vancomycin | 1991 |
Daptomycin versus vancomycin treatment for Staphylococcus aureus bacteremia in a murine model.
Topics: Animals; Daptomycin; Female; Mice; Microbial Sensitivity Tests; Peptides; Sepsis; Staphylococcal Infections; Vancomycin | 1990 |
Hong Kong strains of methicillin-resistant and methicillin-sensitive Staphylococcus aureus have similar virulence.
Topics: Animals; Disease Models, Animal; Humans; Male; Methicillin; Mice; Mice, Inbred ICR; Penicillin Resistance; Prospective Studies; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Virulence | 1990 |
Lactobacillus rhamnosus septicemia in patients with prolonged aplasia receiving ceftazidime-vancomycin.
Topics: Ceftazidime; Humans; Lactobacillus; Neutropenia; Sepsis; Vancomycin | 1991 |
[Staphylococcus aureus sepsis in patients with hematological malignancies: increase in MRSA sepsis].
Topics: Adult; Aged; Aged, 80 and over; Chloramphenicol; Female; Humans; Leukemia; Male; Methicillin Resistance; Middle Aged; Minocycline; Prognosis; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1991 |
Recovery of vancomycin-resistant gram-positive cocci from children.
Topics: Child; Cross-Sectional Studies; Culture Media; Diarrhea; Drug Resistance, Microbial; Enterococcus faecalis; Feces; Gram-Positive Bacteria; Humans; Lactobacillus; Leuconostoc; Sepsis; Streptococcus; Vancomycin | 1990 |
Failure of teicoplanin therapy in two neutropenic patients with staphylococcal septicemia who recovered after administration of vancomycin.
Topics: Adult; Drug Resistance, Microbial; Female; Glycopeptides; Humans; Male; Microbial Sensitivity Tests; Neutropenia; Remission Induction; Sepsis; Species Specificity; Staphylococcal Infections; Teicoplanin; Vancomycin | 1990 |
Streptococcus mitis sepsis in bone marrow transplant patients receiving oral antimicrobial prophylaxis.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Bone Marrow Transplantation; Drug Resistance, Microbial; Female; Humans; Male; Norfloxacin; Polymyxins; Premedication; Sepsis; Streptococcal Infections; Streptococcus; Tobramycin; Utah; Vancomycin | 1990 |
Septicemia caused by vancomycin-resistant Pediococcus acidilactici.
Topics: Bacterial Infections; Bacteriological Techniques; Drug Resistance, Microbial; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Pediococcus; Sepsis; Vancomycin | 1990 |
Vancomycin resistance in Staphylococcus haemolyticus causing colonization and bloodstream infection.
Topics: Aged; Aged, 80 and over; Bacterial Typing Techniques; Drug Resistance, Microbial; Female; Humans; Microbial Sensitivity Tests; Sepsis; Staphylococcal Infections; Staphylococcus; Vancomycin | 1990 |
Enterococci from blood cultures during 1980-1989: susceptibility to ampicillin, penicillin and vancomycin.
Topics: Ampicillin; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Penicillins; Sepsis; Streptococcus; Time Factors; Vancomycin | 1990 |
Extra hospital stay and antibiotic usage with nosocomial coagulase-negative staphylococcal bacteremia in two neonatal intensive care unit populations.
Topics: Cross Infection; Female; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Length of Stay; Male; Sepsis; Staphylococcal Infections; Vancomycin | 1990 |
Safety of vancomycin in acute porphyria.
Topics: Acute Disease; Adult; Aminolevulinic Acid; Erythrocytes; Female; Humans; Hydroxymethylbilane Synthase; Porphobilinogen; Porphyrias; Sepsis; Staphylococcal Infections; Vancomycin | 1990 |
Vancomycin-resistant Pediococcus acidilactici: nine cases of bacteremia.
Topics: Aged; Aged, 80 and over; Drug Resistance, Microbial; Female; Humans; Ileum; Infant, Newborn; Intestinal Atresia; Jejunum; Male; Middle Aged; Opportunistic Infections; Pediococcus; Sepsis; Vancomycin | 1990 |
Bacteremia caused by a vancomycin-resistant Enterococcus.
Topics: Ampicillin; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecalis; Humans; Infant; Male; Netilmicin; Sepsis; Streptococcal Infections; Vancomycin | 1989 |
Comparative in vitro activities of teicoplanin, vancomycin, oxacillin, and other antimicrobial agents against bacteremic isolates of gram-positive cocci.
Topics: Anti-Bacterial Agents; Glycopeptides; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Oxacillin; Sepsis; Teicoplanin; Vancomycin | 1989 |
Persistent bacteremia due to coagulase-negative staphylococci in low birth weight neonates.
Topics: Amikacin; Bacteriophage Typing; Coagulase; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Male; Methicillin; Sepsis; Species Specificity; Staphylococcal Infections; Staphylococcus; Vancomycin | 1989 |
What's in a name? Is methicillin-resistant Staphylococcus aureus just another S aureus when treated with vancomycin?
Topics: Burns; Humans; Methicillin; Penicillin Resistance; Pneumonia, Staphylococcal; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1989 |
[Frequency and severity of systemic infections caused by Streptococcus mitis and sanguis II in neutropenic children].
Topics: Adolescent; Agranulocytosis; Child; Child, Preschool; Female; Humans; Male; Microbial Sensitivity Tests; Neutropenia; Penicillins; Sepsis; Streptococcal Infections; Streptococcus sanguis; Vancomycin | 1989 |
Methicillin-resistant Staphylococcus aureus bacteraemia in Hong Kong.
Topics: Cross Infection; Hong Kong; Humans; Methicillin; Penicillin Resistance; Plasmids; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1988 |
Short-course therapy for catheter-associated Staphylococcus aureus bacteremia.
Topics: Anti-Bacterial Agents; Catheterization; Cephalothin; Cross Infection; Endocarditis, Bacterial; Follow-Up Studies; Humans; Oxacillin; Prospective Studies; Recurrence; Risk Factors; Sepsis; Staphylococcal Infections; Time Factors; Vancomycin | 1989 |
[Use of ceftazidime combined with netilmicin in the treatment of febrile episodes occurring after bone marrow transplantation in children].
Topics: Bacteria; Bacterial Infections; Bone Marrow Transplantation; Ceftazidime; Child; Child, Preschool; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Netilmicin; Postoperative Complications; Sepsis; Time Factors; Vancomycin | 1988 |
[Initial antibacterial prophylaxis after bone marrow allograft. Pilot study with systemic vancomycin].
Topics: Adolescent; Adult; Bone Marrow Transplantation; Capnocytophaga; Child; Child, Preschool; Humans; Middle Aged; Pilot Projects; Postoperative Complications; Premedication; Sepsis; Transplantation, Homologous; Vancomycin | 1988 |
[A case of septicemia caused by Alcaligenes dentrificans subspecies xylosoxidans and a review of the literature].
Topics: Aged; Alcaligenes; Aortic Valve Insufficiency; Cross Infection; Drug Therapy, Combination; Humans; Hypertension; Male; Minocycline; Sepsis; Vancomycin | 1986 |
Clinical laboratory challenges in the recognition of Leuconostoc spp.
Topics: beta-Lactamases; Catheterization, Central Venous; Chromatography, Gas; Culture Media; Drug Resistance, Microbial; Enteral Nutrition; Gastrostomy; Humans; Infant; Leuconostoc; Parenteral Nutrition; Penicillins; Sepsis; Vancomycin | 1988 |
Corynebacterium xerosis septicaemia in a haemodialysis patient.
Topics: Adult; Corynebacterium Infections; Humans; Kidney Failure, Chronic; Male; Renal Dialysis; Sepsis; Vancomycin | 1988 |
Acute interstitial nephritis associated with vancomycin therapy.
Topics: Acute Disease; Adult; Female; Humans; Injections, Intravenous; Nephritis, Interstitial; Sepsis; Staphylococcal Infections; Surgical Wound Infection; Uremia; Vancomycin | 1988 |
Infection with vancomycin-resistant "streptococci" due to Leuconostoc species.
Topics: Bacterial Infections; Diagnosis, Differential; Drug Resistance; Food Contamination; Humans; Infant Food; Infant, Newborn; Leuconostoc; Male; Sepsis; Streptococcal Infections; Vancomycin | 1988 |
Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia.
Topics: Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Drug Therapy, Combination; Fever; Gram-Positive Bacteria; Humans; Neoplasms; Neutropenia; Random Allocation; Retrospective Studies; Sepsis; Staphylococcus; Streptococcus; Vancomycin | 1988 |
Bacteremia in patients undergoing oral procedures. Study following parenteral antimicrobial prophylaxis as recommended by the American Heart Association, 1977.
Topics: Anti-Bacterial Agents; Bacteria; Dental Care; Drug Therapy, Combination; Heart Valve Diseases; Humans; Penicillin G; Premedication; Sepsis; Streptomycin; Vancomycin | 1988 |
Recovery of resistant enterococci during vancomycin prophylaxis.
Topics: Aged; Drug Resistance, Microbial; Humans; Male; Microbial Sensitivity Tests; Premedication; Sepsis; Streptococcus; Vancomycin | 1988 |
Catheter-associated infection with a vancomycin-resistant gram-positive coccus of the Leuconostoc sp.
Topics: Bacterial Infections; Catheterization, Central Venous; Drug Resistance, Microbial; Female; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Leuconostoc; Sepsis; Vancomycin | 1988 |
Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy.
Topics: Adult; Drug Administration Schedule; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Follow-Up Studies; Humans; Injections, Intravenous; Male; Nafcillin; Recurrence; Sepsis; Staphylococcal Infections; Substance-Related Disorders; Tobramycin; Vancomycin | 1988 |
CT-guided percutaneous aspiration of septic thrombosis of the inferior vena cava.
Topics: Adolescent; Biopsy, Needle; Catheters, Indwelling; Female; Gentamicins; Humans; Sepsis; Thrombosis; Tomography, X-Ray Computed; Vancomycin; Vena Cava, Inferior | 1987 |
Staphylococcus aureus bacteremia during therapy.
Topics: Adult; Aged; Anti-Bacterial Agents; Female; Humans; Male; Middle Aged; Nafcillin; Retrospective Studies; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1987 |
Measurement of serum bactericidal activity and use of vancomycin for treatment of nutritionally variant streptococcal bacteremia.
Topics: Humans; Male; Middle Aged; Sepsis; Streptococcal Infections; Streptococcus; Vancomycin | 1987 |
Ciprofloxacin versus vancomycin in the therapy of experimental methicillin-resistant Staphylococcus aureus endocarditis.
Topics: Animals; Ciprofloxacin; Drug Evaluation, Preclinical; Endocarditis, Bacterial; Kinetics; Methicillin; Penicillin Resistance; Rabbits; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1987 |
Antibiotic cost savings from formulary restrictions and physician monitoring in a medical-school-affiliated hospital.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Cost Control; Costs and Cost Analysis; Drug Utilization; Formularies, Hospital as Topic; Hospital Bed Capacity, 500 and over; Hospitals, Teaching; Humans; Missouri; Pharmacy Service, Hospital; Regression Analysis; Retrospective Studies; Sepsis; Vancomycin | 1987 |
Persistent staphylococcal bacteremia in an intravenous drug abuser.
Topics: Adult; Drug Combinations; Heparin; Heroin; Humans; Infusions, Parenteral; Male; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Substance-Related Disorders; Thrombophlebitis; Vancomycin | 1986 |
[Antibiotic-resistant Corynebacteria--a new problem of infection in immunosuppressed patients].
Topics: Anti-Bacterial Agents; Corynebacterium; Corynebacterium Infections; Drug Resistance, Microbial; Female; Humans; Immunosuppression Therapy; Male; Middle Aged; Sepsis; Vancomycin | 1986 |
[The significance of "nonpathogenic" Corynebacteria as a cause of opportunistic infections].
Topics: Catheterization; Corynebacterium; Corynebacterium Infections; Endocarditis; Humans; Meningitis; Opportunistic Infections; Plastics; Sepsis; Skin; Vancomycin | 1986 |
Antimicrobial chemotherapy of septicemia due to methicillin-resistant Staphylococcus aureus.
Topics: Adult; Aged; Amikacin; Drug Combinations; Female; Humans; Male; Methicillin; Middle Aged; Penicillin Resistance; Sepsis; Staphylococcal Infections; Sulfamethoxazole; Tetracycline; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1985 |
Prevention of bacterial endocarditis. A statement for health professionals by the Committee on Rheumatic Fever and Bacterial Endocarditis of the Council on Cardiovascular Diseases in the Young of the American Heart Association.
Topics: American Hospital Association; Ampicillin; Anti-Bacterial Agents; Cardiac Surgical Procedures; Dentistry, Operative; Endocarditis, Bacterial; Female; Gastrointestinal Diseases; Genital Diseases, Female; Genital Diseases, Male; Gentamicins; Humans; Male; Penicillin V; Postoperative Complications; Premedication; Respiratory Tract Diseases; Risk; Sepsis; United States; Vancomycin | 1985 |
Infections in heroin addicts.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Microbial; Endocarditis, Bacterial; Humans; Kanamycin; Morphine Dependence; Sepsis; Staphylococcal Infections; Vancomycin | 1967 |
[Reputedly nephrotoxic antibiotic therapy during severe infections].
Topics: Acute Kidney Injury; Adolescent; Adult; Amphotericin B; Anti-Bacterial Agents; Bacterial Infections; Colistin; Deafness; Endocarditis, Bacterial; Female; Humans; Kanamycin; Kidney; Kidney Function Tests; Male; Middle Aged; Pseudomonas Infections; Sepsis; Staphylococcal Infections; Streptococcal Infections; Urea; Vancomycin | 1972 |
[Vancomycin in staphylococcus septicemia (author's transl)].
Topics: Adult; Diabetes Complications; Drug Evaluation; Drug Resistance, Microbial; Humans; Male; Sepsis; Staphylococcal Infections; Vancomycin | 1974 |
Bacteremia and endocarditis caused by satelliting streptococci.
Topics: Adult; Ampicillin; Bacteria; Cephalothin; Child; Chloramphenicol; Culture Media; Cysteine; Endocarditis, Subacute Bacterial; Erythromycin; Female; Humans; Lincomycin; Liver Cirrhosis; Male; Microbial Sensitivity Tests; Middle Aged; Penicillin Resistance; Penicillins; Sepsis; Streptococcal Infections; Streptococcus; Tetracycline; Thioglycolates; Vancomycin | 1974 |
Group D streptococcal bacteremia, with emphasis on the incidence and presentation of infections due to Streptococcus bovis.
Topics: Ampicillin; Anti-Bacterial Agents; Blood Bactericidal Activity; Cephalothin; Clindamycin; Endocarditis, Bacterial; Endocarditis, Subacute Bacterial; Erythromycin; Gentamicins; Humans; New York City; Oxacillin; Penicillins; Sepsis; Streptococcal Infections; Streptococcus; Streptomycin; Tetracycline; Vancomycin | 1973 |
[Biology of the L-phase of group A streptococci].
Topics: Acute Disease; Animals; Autopsy; Haplorhini; Kidney; L Forms; Liver; Lung; Mice; Penicillins; Peritoneum; Sepsis; Streptococcal Infections; Streptococcus; Vancomycin | 1970 |
Penicillin resistant staphylococcal septicaemia successfully treated with vancomycin and fucidin.
Topics: Adult; Female; Fusidic Acid; Humans; Penicillin Resistance; Sepsis; Staphylococcal Infections; Vancomycin | 1972 |
[Staphylococcal sepsis with bacterial meningoencephalitis and hypokalemic kidney damage treated with vancomycin].
Topics: Cephalothin; Chloramphenicol; Humans; Hypokalemia; Male; Meningoencephalitis; Middle Aged; Oxacillin; Penicillin G; Penicillin Resistance; Polyuria; Potassium; Sepsis; Staphylococcal Infections; Vancomycin; Vasopressins | 1969 |
Staphylococcal infections in nurseries.
Topics: Ampicillin; Bacitracin; Cephalosporins; Chloramphenicol; Cross Infection; Erythromycin; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature, Diseases; Methicillin; Novobiocin; Penicillin G; Sepsis; Tetracycline; Troleandomycin; Vancomycin | 1966 |
Life-threatening infection. Choice of alternate drugs when penicillin cannot be given.
Topics: Cephalothin; Chloramphenicol; Drug Hypersensitivity; Endocarditis, Subacute Bacterial; Humans; Meningitis; Meningitis, Haemophilus; Meningitis, Meningococcal; Meningitis, Pneumococcal; Penicillins; Sepsis; Sodium; Staphylococcal Infections; Succinates; Vancomycin | 1969 |
[Treatment of enterococcal septicemia and endocarditis].
Topics: Ampicillin; Anti-Bacterial Agents; Drug Synergism; Endocarditis, Bacterial; Humans; Penicillin G; Penicillins; Sepsis; Streptococcal Infections; Streptomycin; Tetracycline; Vancomycin | 1971 |
Recurrent septic pulmonary embolism complicating maintenance hemodialysis.
Topics: Adult; Alkaline Phosphatase; Aspartate Aminotransferases; Atrial Fibrillation; Bilirubin; Cephalothin; Chloramphenicol; Female; Humans; Male; Pericarditis; Pulmonary Embolism; Renal Dialysis; Sepsis; Vancomycin | 1969 |
[Post-abortum staphylococcal tricuspid endocarditis cured by surgical excision and Starr's prosthesis].
Topics: Abortion, Septic; Adult; Anti-Bacterial Agents; Bacteriocins; Electrocardiography; Endocarditis, Bacterial; Female; Gentamicins; Heart Valve Prosthesis; Hepatomegaly; Humans; Hysterectomy; Pelvis; Pregnancy; Pulmonary Embolism; Sepsis; Staphylococcal Infections; Streptococcus; Thrombophlebitis; Tricuspid Valve; Vancomycin | 1969 |